Document:

Amendment No. 3 to Term Loan Agreement

 Exhibit 10.1 
 Execution Copy 
 AMENDMENT NO. 3 

AMENDMENT NO. 3 dated as of March 11, 2011 (this “Amendment No. 3”) to the Term Loan Agreement dated as of
October 12, 2007, as amended and restated as of March 12, 2008, as amended by Amendment No. 1, dated as of November 4, 2009 and Amendment No. 2, dated as of December 2, 2010, and as otherwise modified and supplemented
as in effect on the date hereof (the “Term Loan Agreement”) among CDW LLC, an Illinois limited liability company (successor by merger to CDW Corporation, successor by merger to VH MergerSub, Inc.) (“CDW” or the
“Borrower”), CDW Corporation, a Delaware corporation (formerly known as VH Holdings, Inc.) (“Holdings”), each of the Subsidiary Guarantors, each of the Lenders party hereto (collectively the
“Lenders” and, individually, a “Lender”), Morgan Stanley Senior Funding, Inc. (as successor to Lehman Commercial Paper Inc.), as Administrative Agent, and Morgan Stanley & Co. Incorporated (as successor to
Lehman Commercial Paper Inc.), as Collateral Agent. 
 WHEREAS, the Borrower and the Lenders wish to amend the Term Loan
Agreement in certain respects as of the Amendment No. 3 Pricing Change Effective Date (as defined below) to, among other things, reduce the Applicable Percentage with respect to the Extended Term Loans; 

WHEREAS, under Section 9.08(b) of the Term Loan Agreement, an amendment to the Term Loan Agreement cannot decrease the rate of
interest applicable to any Term Loan without the prior written consent of each Lender directly and adversely affected thereby; 

WHEREAS, under Section 2.21 of the Term Loan Agreement (a) if any Lender refuses to consent to any amendment to the Term Loan
Agreement (such lender, a “Non-Consenting Lender”) requested by the Borrower that requires the consent of all affected Lenders and such amendment is consented to by the Required Lenders, the Borrower may, at its sole cost and
expense, upon notice to such Non-Consenting Lender and upon the consent of the Administrative Agent, replace such Non-Consenting Lender by causing such Non-Consenting Lender to assign its respective portion of the Assigned Interests (as defined
below) to one or more Persons; provided that the replacement Lender shall agree to the amendment to which the Non-Consenting Lender did not agree and (b) each Lender has granted to the Administrative Agent an irrevocable power of
attorney to execute and deliver, on behalf of such Lender as assignor, any assignment agreement that is reasonably approved by the Administrative Agent and necessary to effectuate any assignment of such Lender’s interests under the Term Loan
Agreement in respect of the circumstances contemplated by Section 2.21 of the Term Loan Agreement; 
 WHEREAS, the Borrower
and the Lenders wish to amend Section 2.21 of the Term Loan Agreement as of the Amendment No. 3 Effective Date (as defined below) to allow the Borrower to cause a Lender to assign 100% of the principal amount of its outstanding Extended
Term Loans or 100% of the principal amount of its outstanding Non-Extended Term Loans without being required to cause such Lender to assign the other class of Term Loans; 
 WHEREAS, after the Amendment No. 3 Effective Date and immediately prior to the occurrence of the Amendment No. 3 Pricing Change Effective Date (the “Initial Assignment Time”),
the Borrower wishes to cause to be assigned the Extended Term Loans of the Extending Term Loan Lenders which do not consent to this Amendment No. 3 (each such Extending Term Loan Lender, a “Non-Consenting Extending Term Loan
Lender”) pursuant to this Amendment No. 3 to new lenders which execute this Amendment No. 3 and/or existing Lenders which elect to increase their holdings of Extended Term Loans (collectively, the “Assignees”) and
the Assignees wish to purchase and assume such Extended Term Loans and to consent to this Amendment No. 3; provided, that if the aggregate principal amount of Extended Term Loans that the Assignees request to assume pursuant to their
signature pages hereto (the principal amount of such requested assumptions, the “Requested Assumption Amounts”) 

 
exceeds the aggregate principal amount of Extended Term Loans held by Non-Consenting Extending Term Loan Lenders (such excess, the “Initial Commitment Excess”), such Extended
Term Loans shall be assigned to the Assignees in the respective amounts so notified to the Assignees by J.P. Morgan Securities LLC as a joint arranger and bookrunner (the “Arranger”) pursuant to Section 9, which amounts
may be less, but shall not be more, than the Assignees’ respective Requested Assumption Amounts; and 
 WHEREAS, on the
Amendment No. 3 Pricing Change Effective Date, the Extending Term Loan Lenders which (a) consent to this Amendment No. 3 and (b) so request pursuant to their signature pages hereto (such Extending Term Loan Lenders, the
“Consenting Lender Assignors”), wish to assign their Extended Term Loans in an aggregate principal amount equal to the Requested Assignment Amounts (as defined below) pursuant to this Amendment No. 3 to the Assignees and the
Assignees wish to purchase and assume such Extended Term Loans in an aggregate principal amount equal to the Initial Commitment Excess; provided, that (i) if the aggregate of the Requested Assignment Amounts exceeds the Initial
Commitment Excess, the aggregate principal amount of the Extended Term Loans to be assigned by the Consenting Lender Assignors to the Assignees pursuant to Section 5 shall be an amount equal to the Initial Commitment Excess, and the
principal amount of Extended Term Loans to be assigned pursuant to Section 5 by each Consenting Lender Assignor shall be the amount so notified to such Consenting Lender Assignor by the Arranger pursuant to Section 9, which
amount may be less, but shall not be more, than such Consenting Lender Assignor’s Requested Assignment Amount, and (ii) if the Initial Commitment Excess exceeds the aggregate of the Requested Assignment Amounts, the aggregate principal
amount of Extended Term Loans to be assigned by the Consenting Lender Assignors to the Assignees pursuant to Section 5 shall be an amount equal to the aggregate of the Requested Assignment Amounts, and the principal amount of Extended
Term Loans to be assigned to each Assignee pursuant to Section 5 shall be the amount so notified to such Assignee by the Arranger pursuant to Section 9, which amount may be less, but shall not be more, than such
Assignee’s Requested Assumption Amount; 
 NOW, THEREFORE, the parties hereto hereby agree as follows: 

Section 1. Definitions. Capitalized terms used in this Amendment No. 3 and not otherwise defined are used herein as
defined in the Term Loan Agreement (as amended hereby). 
 Section 2. Amendment of Section 2.21 of the Term Loan
Agreement. Effective as of the Amendment No. 3 Effective Date, the Term Loan Agreement shall be amended as follows: 

2.01. References in the Term Loan Agreement (including references to the Term Loan Agreement as amended hereby) to “this
Agreement” (and indirect references such as “hereunder”, “hereby”, “herein” and “hereof”) shall be deemed to be references to the Term Loan Agreement as amended hereby. 

2.02. Section 1.01 of the Term Loan Agreement shall be amended by inserting the following definition in the appropriate alphabetical
location: 
 ““Class”, (a) when used in reference to any Term Loans, refers to whether
such Term Loans are Extended Term Loans or Non-Extended Term Loans, and (b) when used in reference to any Term Loan Lenders, refers to whether such Term Loan Lenders are Extending Term Loan Lenders or Non-Extending Term Loan Lenders.”

  
 - 2 -

 2.03. Section 2.21(a) of the Term Loan Agreement shall be amended and restated in its
entirety to read as follows: 
 “(a) In the event (i) any Term Loan Lender of any Class requests
compensation pursuant to Section 2.14, (ii) any Term Loan Lender of any Class delivers a notice described in Section 2.15, (iii) the Borrower is required to pay any additional amount to any Term Loan Lender of any
Class or any Governmental Authority on account of any Term Loan Lender of any Class pursuant to Section 2.20, (iv) any Term Loan Lender of any Class shall become a Defaulting Lender or (v) any Term Loan Lender of any Class
refuses to consent to any amendment, waiver or other modification of any Loan Document requested by the Borrower that requires the consent of all affected Lenders of such Class in accordance with the terms of Section 9.08 or all the
Lenders of such Class and such amendment, waiver or other modification is consented to by the Required Lenders (any such Term Loan Lender of such Class, a “Non-Consenting Lender”), the Borrower may, at its sole cost and expense,
upon notice to such Term Loan Lender of such Class and upon the consent of the Administrative Agent, which shall not be unreasonably withheld, either: 
 (x) replace such Term Loan Lender of such Class by causing such Term Loan Lender to (and such Term Loan Lender shall be obligated to) assign, at par, 100% of the principal amount of its outstanding Term
Loans of such Class, plus any accrued and unpaid interest on such Term Loans pursuant to Section 9.04 (with the assignment fee to be waived in such instance) and all of its rights and obligations as a Term Loan Lender of such Class under
this Agreement in respect of the Term Loans of such Class to one or more Persons (which Persons shall otherwise be subject to the approval rights set forth in Section 9.04(b)); provided that (I)(A) the replacement Lender
shall agree to the consent, waiver or amendment to which the Non-Consenting Lender did not agree, (B) neither the Administrative Agent nor any Lender shall have any obligation to the Borrower to find a replacement Lender or other such Person
and (C) in the case of any such assignment resulting from a claim for compensation under Section 2.14 or payments required to be made pursuant to Section 2.20, such assignment will result in a reduction in such
compensation or payments and (II) the Borrower shall pay to such Term Loan Lender all Obligations (other than (i) contingent obligations, (ii) principal paid by the assignee and (iii) accrued interest, which shall be paid by Borrower
when due and allocated by the Administrative Agent to the assignor and assignee in accordance with their respective periods of ownership of the applicable Term Loans assigned) in respect of the Term Loans of such Class owing to such Term Loan Lender
as of the date of such assignment; or 
 (y) repay all Obligations (other than contingent obligations) in respect
of the Term Loans of such Class owing to such Term Loan Lender as of such termination date. 
 Each Lender hereby grants to the
Administrative Agent an irrevocable power of attorney (which power is coupled with an interest) to execute and deliver, on behalf of such Lender as assignor, any Assignment and Acceptance necessary to effectuate any assignment of such Lender’s
interests hereunder in respect of the circumstances contemplated by this Section 2.21.”. 
 Section 3.
Assignment of Assigned Interests of the Non-Consenting Extending Term Loan Lenders. Effective as of the Initial Assignment Time: 
 (a) The Loan Parties and the Required Lenders hereby agree that, notwithstanding Sections 2.21 and 9.04 of the Term Loan Agreement, the assignment of the Assigned Interests (as defined below) of the
Non-Consenting Extending Term Loan Lenders shall be consummated pursuant to this Amendment No. 3 (and no assignment fee shall be payable in connection therewith). 

  
 - 3 -

 (b) The Administrative Agent, as attorney-in-fact for the Non-Consenting Extending Term
Loan Lenders in respect of the circumstances contemplated by and as provided in Section 2.21 of the Term Loan Agreement (as amended hereby), hereby irrevocably sells and assigns to the Assignees and the Assignees hereby irrevocably purchase and
assume, at par, at and as of the Initial Assignment Time, (i) 100% of the principal amount of the Non-Consenting Extending Term Loan Lenders’ outstanding Extended Term Loans, (ii) the Non-Consenting Extending Term Loan Lenders’
rights and obligations in their capacities as Extending Term Loan Lenders under the Term Loan Agreement and any other documents or instruments delivered pursuant thereto to the extent related to all of such outstanding rights and obligations of such
Non-Consenting Extending Term Loan Lenders under the Term Loan Facility, in respect of the Extended Term Loans and (iii) to the extent permitted to be assigned under applicable law, all claims, suits, causes of action and any other right of the
Non-Consenting Extending Term Loan Lenders (in their capacities as Extending Term Loan Lenders) against any Person, whether known or unknown, arising under or in connection with the Term Loan Agreement, any other documents or instruments delivered
pursuant thereto or the loan transactions governed thereby or in any way based on or related to any of the foregoing, including, but not limited to, contract claims, tort claims, malpractice claims, statutory claims and all other claims at law or in
equity related to the rights and obligations sold and assigned pursuant to clauses (i) and (ii) above (the rights and obligations sold and assigned to the Assignee pursuant to clauses (i), (ii) and (iii) above being referred to
herein collectively as the “Assigned Interests”). Each such sale and assignment is without recourse to each Non-Consenting Extending Term Loan Lender and the Administrative Agent and, except as expressly provided herein, without
representation or warranty by any Non-Consenting Extending Term Loan Lender or the Administrative Agent. Immediately after giving effect to the foregoing assignments and assumptions, the outstanding principal amounts of the Extended Term Loans so
assigned and assumed pursuant to this Section 3 shall be held by the Assignees in the respective amounts so notified to the Assignees by the Arranger pursuant to Section 9 (the “Section 3 Assignee Allocation
Amounts”), which amounts may be less, but shall not be more, than the Assignees’ respective Requested Assumption Amounts. The Extended Term Loans assigned by each Non-Consenting Extending Term Loan Lender pursuant to this
Section 3 shall be deemed to have been assigned to the Assignees pro rata in accordance with their respective Section 3 Assignee Allocation Amounts. Each Assignee shall pay to the Administrative Agent for the accounts of the
respective Non-Consenting Extending Term Loan Lenders, in immediately available funds at the Initial Assignment Time, an amount equal to the outstanding principal amount of the Extended Term Loans assumed by such Assignee pursuant to this
Section 3. For the avoidance of doubt the Assigned Interests do not included any Non-Extended Term Loans or any rights or obligations in respect of the Non-Extended Term Loans. 

(c) Each Assignee (i) represents and warrants to the Administrative Agent and to each Non-Consenting Extending Term Loan Lender in
respect of the circumstances contemplated by and as provided in Section 2.21 of the Term Loan Agreement, that, as of the Initial Assignment Time, (A) it has full power and authority, and has taken all action necessary, to execute and
deliver this Amendment No. 3 and to consummate the transactions contemplated hereby and to become an Extending Term Loan Lender under the Term Loan Agreement, (B) it meets all the requirements to be an assignee under the Term Loan
Agreement (subject to such consents, if any, as may be required under the Term Loan Agreement), (C) from and after the Initial Assignment Time, it shall be bound by the provisions of the Term Loan Agreement as an Extending Term Loan Lender
thereunder and, to the extent of the Assigned Interests purchased and assumed by it, shall have the obligations of an Extending Term Loan Lender thereunder, 

  
 - 4 -

 
(D) it is sophisticated with respect to decisions to acquire assets of the type represented by the Assigned Interests and either it, or the person exercising discretion in making its decision to
acquire its respective portion of the Assigned Interests, is experienced in acquiring assets of such type, (E) it has received a copy of the Term Loan Agreement, and has received or has been accorded the opportunity to receive copies of the
most recent financial statements delivered pursuant to the Term Loan Agreement, as applicable, and such other documents and information as it deems appropriate to make its own credit analysis and decision to enter into this Amendment No. 3 and
to purchase its respective portion of the Assigned Interests, (F) it has, independently and without reliance upon the Administrative Agent or any other Lender and based on such documents and information as it has deemed appropriate, made its
own credit analysis and decision to enter into this Amendment No. 3 and to purchase its respective portion of the Assigned Interests, and (G) if it is a Foreign Lender, it has delivered to the Administrative Agent any documentation
required to be delivered by it pursuant to the terms of the Tern Loan Agreement, duly completed and executed by the Assignee, (ii) agrees that (A) it will, independently and without reliance on the Administrative Agent or any Lender, and
based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Loan Documents, and (B) it will perform in accordance with their terms all of
the obligations which by the terms of the Loan Documents are required to be performed by it as an Extending Term Loan Lender, and (iii) understands and agrees that the Administrative Agent shall not have any liability (and each Assignee agrees
not to assert that the Administrative Agent shall have any such liability) for the inaccuracy of any representation or warranty made in clause (d) below and that any such liability for the inaccuracy of any such representation or warranty shall
be solely that of the applicable Non-Consenting Extending Term Loan Lender. 
 (d) In connection with the assignments under
Section 3(b), each Non-Consenting Extending Term Loan Lender is hereby deemed to (i) represent and warrant to the Assignees that, as of the Initial Assignment Time, (A) it is the legal and beneficial owner of its respective
portion of the Assigned Interests, (B) its respective portion of the Assigned Interests is free and clear of any lien, encumbrance or other adverse claim and (C) it has full power and authority, and has taken all action necessary, to
authorize the Administrative Agent on its behalf as attorney-in-fact to execute and deliver this Amendment No. 3 and to consummate the transactions contemplated hereby, and (ii) assume no responsibility with respect to (A) any
statements, warranties or representations made in or in connection with the Term Loan Agreement or any other Loan Document, (B) the execution, legality, validity, enforceability, genuineness, sufficiency or value of the Loan Documents or any
collateral thereunder, (C) the financial condition of the Borrower, any of its Subsidiaries or Affiliates or any other Person obligated in respect of any Loan Document or (D) the performance or observance by the Borrower, any of its
Subsidiaries or Affiliates or any other Person of any of their respective obligations under any Loan Document. 
 (e) From and
after the Initial Assignment Time, the Administrative Agent shall make all payments in respect of the Assigned Interests (including payments of principal, interest, fees and other amounts) to the Non-Consenting Lenders for amounts which have accrued
to but excluding the Initial Assignment Time and to the Assignees for amounts which have accrued from and after the Initial Assignment Time. 
 Section 4. Amendments. Effective as of the Amendment No. 3 Pricing Change Effective Date, the Term Loan Agreement shall be amended as follows: 

4.01. Section 1.01 of the Term Loan Agreement shall be amended by (a) amending the following definitions (to the extent already
included in Section 1.01), and (b) inserting the following definitions in the appropriate alphabetical location (to the extent not already included in Section 1.01): 

““Adjusted LIBO Rate” shall mean, (a) with respect to any Eurodollar Borrowing of Non-Extended
Term Loans, for any Interest Period, an interest rate per annum equal to the product of (i) the LIBO Rate in effect for such Interest Period and (ii) Statutory Reserves; and (b) with respect to any Eurodollar Borrowing of Extended
Term Loans, from and after the Amendment No. 3 Pricing Change Effective Date, for any Interest Period, an interest rate per annum equal to the greater of (i) 1.25% and (ii) the product of (A) the LIBO Rate in effect for such
Interest Period and (B) Statutory Reserves.” 

  
 - 5 -

 ““Alternate Base Rate” shall mean, for any day,
(a) with respect to any Non-Extended Term Loans, a rate per annum equal to the greatest of (i) the Prime Rate in effect on such day and (ii) the Federal Funds Effective Rate in effect on such day plus 1/2 of 1% and (b) with
respect to any Extended Term Loans, from and after the Amendment No. 3 Pricing Change Effective Date, a rate per annum equal to the greater of (i) 2.25%, (ii) the Prime Rate in effect on such day and (iii) the Federal Funds
Effective Rate in effect on such day plus 1/2 of 1%. Any change in the Alternate Base Rate due to a change in the Prime Rate or the Federal Funds Effective Rate shall be effective on the effective date of such change in the Prime Rate or the
Federal Funds Effective Rate, as the case may be.” 
 ““Amendment No. 3” means
that certain Amendment No. 3 dated as of March 11, 2011 to this Agreement, between the Borrower, Holdings, the Subsidiary Guarantors, the Lenders party thereto and the Administrative Agent.” 

““Amendment No. 3 Pricing Change Effective Date” shall mean the date on which the conditions
precedent set forth in Section 7(b) of Amendment No. 3 shall have been satisfied.” 

““Applicable Percentage” shall mean, for any day, 

(a) with respect to any Eurodollar Non-Extended Term Loan and any ABR Non-Extended Term Loan, the applicable percentage
per annum set forth below under the caption “Non-Extended Eurodollar Rate Spread” and “Non-Extended ABR Rate Spread”, as the case may be (based upon the Senior Secured Leverage Ratio as of the relevant date of determination):

  

					
	 Total Senior Secured Leverage Ratio
	  	Non-Extended
Eurodollar Rate
Spread	 	Non-Extended
ABR Rate Spread
			
	 Category 1

Greater than 4.00 to 1.00
	  	4.00%	 	3.00%
			
	 Category 2

Less than or equal to 4.00 to 1.00 but greater than 3.50 to 1.00
	  	3.75%	 	2.75%
			
	 Category 3

Less than or equal to 3.50 to 1.00
	  	3.50%	 	2.50%

 (b)
with respect to any Eurodollar Extended Term Loan and any ABR Extended Term Loan, from and after the Amendment No. 3 Pricing Change Effective Date, the applicable 

  
 - 6 -

 
percentage per annum set forth below under the caption “Extended Eurodollar Rate Spread” and “Extended ABR Rate Spread”, as the case may be (based upon the Senior Secured
Leverage Ratio as of the relevant date of determination): 
  

					
	 Total Senior Secured Leverage Ratio
	  	Extended
Eurodollar Rate
Spread	 	Extended ABR
Rate Spread
			
	 Category 1

Greater than or equal to 3.50 to 1.00
	  	3.25%	 	2.25%
			
	 Category 2

Less than 3.50 to 1.00 but greater than or equal to 3.00 to 1.00
	  	3.00%	 	2.00%
			
	 Category 3

Less than 3.00 to 1.00
	  	2.75%	 	1.75%

 Each
change in the Applicable Percentage resulting from a change in the Senior Secured Leverage Ratio shall be effective on and after the date of delivery to the Administrative Agent of the Section 5.04 Financials and a Pricing Certificate
indicating such change until and including the date immediately preceding the next date of delivery of such financial statements and the related Pricing Certificate indicating another such change. Notwithstanding the foregoing, until the Borrower
shall have delivered the Section 5.04 Financials and the related Pricing Certificate covering a period that includes the first fiscal quarter of the Borrower ended after the Closing Date, the Senior Secured Leverage Ratio shall be deemed
to be in Category 1 for purposes of determining the Applicable Percentage for the applicable Term Loans. In addition, at the option of the Administrative Agent and the Required Lenders, (x) at any time during which the Borrower has failed
to deliver the Section 5.04 Financials or the related Pricing Certificate by the date required thereunder or (y) at any time after the occurrence and during the continuance of an Event of Default, then the Senior Secured Leverage
Ratio shall be deemed to be in Category 1 for the purposes of determining the Applicable Percentage for the applicable Term Loans (but only for so long as such failure or Event of Default continues, after which the Category shall be otherwise as
determined as set forth above).” 
 4.02. Section 2.12 of the Term Loan Agreement shall be amended by: 

(a) amending clause (a) thereof in its entirety to read as follows: 

“(a) Subject to Section 2.12(d), the Borrower shall have the right at any time and from time to time to
prepay any Borrowing, in whole or in part, upon at least three Business Days’ prior written or fax notice by the Borrower in the case of Eurodollar Term Loans, or written or fax notice by the Borrower at least one Business Day prior to the date
of prepayment in the case of ABR Term Loans, to the Administrative Agent before 12:30 p.m.; provided, however, that each partial prepayment shall be in an aggregate amount of not less than the Minimum Threshold.” 

  
 - 7 -

 (b) inserting at the end thereof a new clause (d) to read in its
entirety as follows: 
 “(d) In the event that all or any portion of the Extended Term Loans are either
repaid through optional prepayments from the incurrence of Indebtedness or repriced (or effectively refinanced) through any amendment of this Agreement, each Extending Term Loan Lender holding Extended Term Loans shall be paid a prepayment premium
equal to 1.00% of the amount of such Extended Term Loans repaid or repriced, if such repayment or repricing is effected prior to the six-month anniversary of the Amendment No. 3 Pricing Change Effective Date.” 

4.03. Section 2.13 of the Term Loan Agreement shall be amended by: 

(a) amending clause (c) thereof in its entirety to read as follows: 

“(c) Subject to Section 2.13(i), in the event that the Borrower or any of its Restricted Subsidiaries
shall receive Net Cash Proceeds from the issuance or incurrence of Indebtedness (other than any cash proceeds from the issuance or incurrence of Indebtedness permitted pursuant to Section 6.01), the Borrower shall no later than the third
Business Day following the receipt of such Net Cash Proceeds, apply an amount equal to 100% of such Net Cash Proceeds to prepay outstanding Term Loans in accordance with Section 2.13(f).” 

(b) amending clause (e) thereof in its entirety to read as follows: 

“(e) Subject to Section 2.13(i), in the event that the Borrower or any of its Restricted Subsidiaries
shall receive Net Cash Proceeds from the issuance of Senior Secured Notes after the Amendment No. 2 Closing Date, the Borrower shall immediately apply an amount equal to 100% of such Net Cash Proceeds to prepay the outstanding Term Loans in
accordance with Section 2.13(f).” 
 (c) inserting at the end thereof a new clause (i) to
read in its entirety as follows: 
 “(i) To the extent that such prepayment premium is not otherwise paid
pursuant to Section 2.12(d), in the event that all or any portion of the Extended Term Loans are either repaid through mandatory prepayments from the incurrence of Indebtedness or repriced (or effectively refinanced) through any
amendment of this Agreement, each Extending Term Loan Lender holding Extended Term Loans shall be paid a prepayment premium equal to 1.00% of the amount of such Extended Term Loans repaid or repriced, if such repayment or repricing is effected prior
to the six-month anniversary of the Amendment No. 3 Pricing Change Effective Date.” 
 4.04. Section 6.03(b)(xi)
of the Term Loan Agreement shall be amended in its entirety to read as follows: 
 “(xi) Other Restricted
Payments in an aggregate amount taken together with all other Restricted Payments made pursuant to this clause (xi), from and after the Amendment No. 3 Pricing Change Effective Date, not to exceed $25,000,000;” 

Section 5. Assignment of Consenting Lender Assigned Interests of the Consenting Lender Assignors. On, and effective as of,
the Amendment No. 3 Pricing Change Effective Date: 
 (a) The Loan Parties and the Required Lenders hereby agree that,
notwithstanding Section 9.04 of the Term Loan Agreement, (i) the assignment of the Consenting Lender Assigned Interests (as defined below) of the Consenting Lender Assignors shall be consummated pursuant to this Amendment No. 3,
(ii) no assignment fee shall be payable in connection therewith, and (iii) the Consenting Lender Assigned Interests may be assigned in any amounts and integral multiples provided herein. 

  
 - 8 -

 (b) The Consenting Lender Assignors hereby irrevocably sell and assign to the Assignees and
the Assignees hereby irrevocably purchase and assume, at par, on and as of the Amendment No. 3 Pricing Change Effective Date, (i) the principal amount of the Consenting Lender Assignors’ outstanding Extended Term Loans that the
Consenting Lender Assignors requested to assign pursuant to their respective signature pages hereto (the principal amount of such requested assignments, the “Requested Assignment Amounts”); provided, that (i) if the
aggregate of the Requested Assignment Amounts exceeds the Initial Commitment Excess, the aggregate principal amount of the Extended Term Loans so assigned by the Consenting Lender Assignors to the Assignees pursuant to this Section 5
shall be an amount equal to the Initial Commitment Excess, and the principal amount of Extended Term Loans so assigned pursuant to this Section 5 by each Consenting Lender Assignor shall be the amount so notified to such Consenting
Lender Assignor by the Arranger pursuant to Section 9, which amount may be less, but shall not be more, than such Consenting Lender Assignor’s Requested Assignment Amount, and (ii) if the Initial Commitment Excess exceeds the
aggregate of the Requested Assignment Amounts, the aggregate principal amount of Extended Term Loans so assigned by the Consenting Lender Assignors to the Assignees pursuant to this Section 5 shall be an amount equal to the aggregate of
the Requested Assignment Amounts, and the principal amount of Extended Term Loans so assigned to each Assignee pursuant to this Section 5 shall be the amount so notified to such Assignee by the Arranger pursuant to Section 9,
which amount may be less, but shall not be more, than such Assignee’s Requested Assumption Amount (such assigned Extended Term Loans, the “Assigned Term Loans”), (ii) the Consenting Lender Assignors’ rights and
obligations in their capacities as Extending Term Loan Lenders under the Term Loan Agreement and any other documents or instruments delivered pursuant thereto to the extent related to all of such outstanding rights and obligations of such Consenting
Lender Assignors under the Term Loan Facility, in respect of the Assigned Term Loans and (iii) to the extent permitted to be assigned under applicable law, all claims, suits, causes of action and any other right of the Consenting Lender
Assignors (in their capacities as Extending Term Loan Lenders and in respect of the Assigned Term Loans) against any Person, whether known or unknown, arising under or in connection with the Term Loan Agreement, any other documents or instruments
delivered pursuant thereto or the loan transactions governed thereby or in any way based on or related to any of the foregoing, including, but not limited to, contract claims, tort claims, malpractice claims, statutory claims and all other claims at
law or in equity related to the rights and obligations sold and assigned pursuant to clauses (i) and (ii) above (the rights and obligations sold and assigned to the Assignee pursuant to clauses (i), (ii) and (iii) above being
referred to herein collectively as the “Consenting Lender Assigned Interests”). Each such sale and assignment is without recourse to each Consenting Lender Assignor and, except as expressly provided herein, without representation or
warranty by any Consenting Lender Assignor. Immediately after giving effect to the foregoing assignments and assumptions, the outstanding principal amounts of the Extended Term Loans so assigned and assumed pursuant to this Section 5
shall be held by the Assignees in the respective amounts so notified to the Consenting Lender Assignors and Assignees by the Arranger pursuant to Section 9 (the “Section 5 Assignee Allocation Amounts”), which amounts,
when combined with the respective Section 3 Assignee Allocation Amounts, may be less, but shall not be more, than each Assignee’s respective Requested Assumption Amount. The Extended Term Loans assigned by each Consenting Lender Assignor
pursuant to this Section 5 shall be deemed to have been assigned to the Assignees pro rata in accordance with their respective Section 5 Assignee Allocation Amounts. Each Assignee shall pay to the Administrative Agent for the
accounts of the respective Consenting Lender 

  
 - 9 -

 
Assignors, in immediately available funds on the Amendment No. 3 Pricing Change Effective Date, an amount equal to the outstanding principal amount of the Extended Term Loans assumed by such
Assignee pursuant to this Section 5. 
 (c) Each Assignee (i) represents and warrants to the Consenting Lender
Assignors and the Administrative Agent that (A) it has full power and authority, and has taken all action necessary, to execute and deliver this Amendment No. 3 and to consummate the transactions contemplated hereby and to become an
Extending Term Loan Lender under the Term Loan Agreement, (B) it meets all the requirements to be an assignee under the Term Loan Agreement (subject to such consents, if any, as may be required under the Term Loan Agreement), (C) from and
after the Amendment No. 3 Pricing Change Effective Date, it shall be bound by the provisions of the Term Loan Agreement as an Extending Term Loan Lender thereunder and, to the extent of the Consenting Lender Assigned Interests purchased and
assumed by it, shall have the obligations of an Extending Term Loan Lender thereunder, (D) it is sophisticated with respect to decisions to acquire assets of the type represented by the Consenting Lender Assigned Interests and either it, or the
person exercising discretion in making its decision to acquire its respective portion of the Consenting Lender Assigned Interests, is experienced in acquiring assets of such type, (E) it has received a copy of the Term Loan Agreement, and has
received or has been accorded the opportunity to receive copies of the most recent financial statements delivered pursuant to the Term Loan Agreement, as applicable, and such other documents and information as it deems appropriate to make its own
credit analysis and decision to enter into this Amendment No. 3 and to purchase its respective portion of the Consenting Lender Assigned Interests, (F) it has, independently and without reliance upon the Administrative Agent or any other
Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Amendment No. 3 and to purchase its respective portion of the Consenting Lender Assigned Interests,
and (G) if it is a Foreign Lender, it has delivered to the Administrative Agent any documentation required to be delivered by it pursuant to the terms of the Tern Loan Agreement, duly completed and executed by the Assignee, and (ii) agrees
that (A) it will, independently and without reliance on the Administrative Agent or any Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not
taking action under the Loan Documents, and (B) it will perform in accordance with their terms all of the obligations which by the terms of the Loan Documents are required to be performed by it as an Extending Term Loan Lender. 

(d) Each Consenting Lender Assignor (i) represents and warrants to the Assignees that (A) it is the legal and beneficial owner
of its respective portion of the Consenting Lender Assigned Interests, (B) its respective portion of the Consenting Lender Assigned Interests is free and clear of any lien, encumbrance or other adverse claim and (C) it has full power and
authority, and has taken all action necessary, to execute and deliver this Amendment No. 3 and to consummate the transactions contemplated hereby, and (ii) assumes no responsibility with respect to (A) any statements, warranties or
representations made in or in connection with the Term Loan Agreement or any other Loan Document, (B) the execution, legality, validity, enforceability, genuineness, sufficiency or value of the Loan Documents or any collateral thereunder,
(C) the financial condition of the Borrower, any of its Subsidiaries or Affiliates or any other Person obligated in respect of any Loan Document or (D) the performance or observance by the Borrower, any of its Subsidiaries or Affiliates or
any other Person of any of their respective obligations under any Loan Document. 
 (e) From and after the Amendment No. 3
Pricing Change Effective Date, the Administrative Agent shall make all payments in respect of the Consenting Lender Assigned Interests (including payments of principal, interest, fees and other amounts) to the Consenting Lender Assignors for amounts
which have accrued to but excluding the Amendment No. 3 Pricing Change Effective Date and to the Assignees for amounts which have accrued from and after the Amendment No. 3 Pricing Change Effective Date. 

  
 - 10 -

 Section 6. Confirmation of Security Interest. The Borrower, by its execution of
this Amendment No. 3, hereby confirms and ratifies that all of its obligations as a “Grantor”, “Mortgagor” and “Trustor” or otherwise under the Security Documents to which it is a party shall continue in full force
and effect for the benefit of the Agents and the Lenders with respect to the Term Loan Agreement as amended hereby. The Borrower, by its execution of this Amendment No. 3, hereby confirms that the security interests granted by it under each of
the Security Documents to which it is a party shall continue in full force and effect in favor of the Collateral Agent for the benefit of the Lenders and the Agents with respect to the Term Loan Agreement as amended hereby. 

Section 7. Conditions Precedent to Effectiveness. 
 (a) This Amendment No. 3 (other than the amendments set forth in Section 4 hereof and the assignments set forth in Section 5 hereof) shall become effective on the date upon
which this Amendment No. 3 has been duly executed and delivered by the Borrower, Holdings, the Subsidiary Guarantors and the Required Lenders and acknowledged by the Administrative Agent (the “Amendment No. 3 Effective
Date”). 
 (b) The amendments set forth in Section 4 hereof and the assignments set forth in
Section 5 hereof shall become effective on the date upon which each of the following conditions is satisfied (the “Amendment No. 3 Pricing Change Effective Date”): 

(i) Amendment No. 3. This Amendment No. 3 shall have been duly executed and delivered by the Borrower,
Holdings, the Subsidiary Guarantors, the Required Lenders and each of the Extending Term Loan Lenders (including each Assignee in its capacity as an Extending Term Loan Lender pursuant to Section 3 and Section 5 hereof) and
acknowledged by the Administrative Agent. 
 (ii) Financial Officer’s Certificates. The
Administrative Agent shall have received a certificate, dated as of the Amendment No. 3 Pricing Change Effective Date and signed by a Financial Officer of the Borrower, certifying compliance with the conditions precedent set forth in
Sections 4.01(b), 4.01(c) and 4.02(i) of the Term Loan Agreement. 
 (iii) No Defaults. No Default or
Event of Default shall have occurred and be continuing under the Term Loan Agreement. 
 (iv) Representations
and Warranties. The representations and warranties set forth in Article III of the Term Loan Agreement and in each other Loan Document shall be true and correct in all material respects on and as of the Amendment No. 3 Pricing Change
Effective Date with the same effect as though made on and as of such date, except to the extent such representations and warranties expressly relate to an earlier date, in which case they shall be true and correct in all material respects as of such
earlier date. 
 (v) Fees and Expenses. The Administrative Agent shall have received (A) all fees and
other amounts due and payable on or prior to the Amendment No. 3 Pricing Change Effective Date, including, to the extent invoiced at least one Business Day prior to the Amendment No. 3 Pricing Change Effective Date, reimbursement or
payment of all reasonable out-of-pocket expenses required to be reimbursed or paid by the Borrower hereunder or under any other Loan Document and (B) all Obligations in respect of the Extended Term Loans (other than contingent obligations and
other than principal paid by the Assignees) owing to each Non-Consenting Extending Term Loan Lender as of the Amendment No. 3 Effective Date. 

  
 - 11 -

 Section 8. Miscellaneous. Except as herein provided, the Term Loan Agreement
shall remain unchanged and in full force and effect. This Amendment No. 3 may be executed in any number of counterparts, all of which taken together shall constitute one and the same agreement and any of the parties hereto may execute this
Amendment No. 3 by signing any such counterpart. This Amendment No. 3 shall be governed by, and construed in accordance with, the law of the State of New York. 
 Section 9. Notifications by Arranger; Consent by Administrative Agent. At least two Business Days before the Initial Assignment Time the Arranger shall notify (i) each Consenting Lender
Assignor of (a) the principal amount of the Extended Term Loans that will be assigned by such Consenting Lender Assignor pursuant to Section 5 of this Amendment No. 3 and (b) the principal amount of Extended Term Loans
that such Consenting Lender Assignor will hold immediately following the consummation of the assignments to be made pursuant to Section 5 of this Amendment No. 3, (ii) each Assignee of (a) the principal amount of the
Extended Term Loans that will be assigned to and assumed by such Assignee pursuant to Section 3 of this Amendment No. 3, (b) the principal amount of the Extended Term Loans that will be assigned to and assumed by such Assignee
pursuant to Section 5 of this Amendment No. 3 and (c) the principal amount of Extended Term Loans that such Assignee will hold immediately following the consummation of the assignments to be made pursuant to
Section 5 of this Amendment No. 3, and (iii) each Non-Consenting Extending Term Loan Lender that its Extended Term Loans will be assigned pursuant to Section 2.21(a) of the Term Loan Agreement (as amended by this Amendment
No. 3) because it has not consented to this Amendment No 3. The Administrative Agent hereby consents to the assignments and assumptions effected pursuant to Sections 3 and 5 of this Amendment No. 3. 

[remainder of page intentionally blank] 

  
 - 12 -

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 3 to be duly
executed and delivered as of the day and year first above written. 
  

			
	Acknowledged by
	 MORGAN STANLEY SENIOR FUNDING, INC,
 as Administrative Agent

		
	By:	 	 /s/ Stephen B. King

	Name:	 	Stephen B. King
	Title:	 	Vice President

  

[SIGNATURE PAGE – AMENDMENT NO. 3] 

 
			
	CDW LLC,
	as Borrower
		
	By:	 	 /s/ Ann E. Ziegler

	Name:	 	 Ann E. Ziegler

	Title:	 	Senior Vice President and Chief Financial Officer

  

[SIGNATURE PAGE – AMENDMENT NO. 3] 

 By its signature below, the undersigned hereby consents to the foregoing Amendment
No. 3 to the Term Loan Agreement and hereby confirms that all of its obligations under each Security Document (as defined in the Term Loan Agreement) shall continue unchanged and in full force and effect for the benefit of the Agents and the
Lenders with respect to the Term Loan Agreement as amended by said Amendment No. 3. 
  

			
	CDW CORPORATION,
	as a Guarantor
		
	By:	 	 /s/ Ann E. Ziegler

	Name:	 	 Ann E. Ziegler

	Title:	 	 Senior Vice President and Chief Financial Officer 

	
	 CDW DIRECT, LLC,
 as a Guarantor

		
	By:	 	 /s/ Ann E. Ziegler

	Name:	 	 Ann E. Ziegler

	Title:	 	 Senior Vice President and Chief Financial Officer 

	
	 CDW GOVERNMENT LLC,
 as a Guarantor

		
	By:	 	 /s/ Ann E. Ziegler

	Name:	 	 Ann E. Ziegler

	Title:	 	 Senior Vice President and Chief Financial Officer 

	
	 CDW TECHNOLOGIES, INC.,
 as a Guarantor

		
	By:	 	 /s/ Ann E. Ziegler

	Name:	 	 Ann E. Ziegler

	Title:	 	 Senior Vice President and Chief Financial Officer 

	
	 CDW LOGISTICS, INC.,
 as a Guarantor

		
	By:	 	 /s/ Ann E. Ziegler

	Name:	 	 Ann E. Ziegler

	Title:	 	 Senior Vice President and Chief Financial Officer 

  

[SIGNATURE PAGE – AMENDMENT NO. 3] 

 
			
	[                           
             ]
	as a Lender
		
	By:	 	  

	Name:	 	
	Title:	 	

 NOTE: THE FOLLOWING INFORMATION NEED NOT BE COMPLETED IF THE LENDER DOES NOT WISH TO INCREASE OR DECREASE
THE PRINCIPAL AMOUNT OF EXTENDED TERM LOANS HELD BY IT IMMEDIATELY FOLLOWING THE OCCURRENCE OF THE AMENDMENT NO. 3 PRICING CHANGE EFFECTIVE DATE. 
 If the Lender (including any Assignee that wishes to become a Lender) wishes to increase or decrease the principal amount of Extended Term Loans held by it immediately following the occurrence of the
Amendment No. 3 Pricing Change Effective Date, indicate below the principal amount that it wishes to so hold: 

$             of its Extended Term Loans 

For purposes of Amendment No. 3, if the amount completed above is greater than the principal amount of Extended Term Loans held by the Lender
immediately prior to the occurrence of the Amendment No. 3 Pricing Change Effective Date, the Lender will be deemed to have requested to assume Extended Term Loans in the amount of such excess (and the amount of such excess will
constitute such Lender’s “Requested Assumption Amount”). 
 For purposes of Amendment No. 3, if the amount completed above
is less than the principal amount of Extended Term Loans held by the Lender immediately prior to the occurrence of the Amendment No. 3 Pricing Change Effective Date, the Lender will be deemed to have requested to assign Extended
Term Loans in the amount of such excess (and the amount of such excess will constitute such Lender’s “Requested Assignment Amount”). 

  

[SIGNATURE PAGE – AMENDMENT NO. 3]Third Amended and Restated Investors' Rights Agreement

 Exhibit 4.2 
 SOLAZYME, INC. 
 THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 MAY 19, 2010 

 Table of Contents 

 

							
	 	  	 	  	Page	 
	 SECTION 1
	  	DEFINITIONS	  	 	1	  
			
	 1.1
	  	Certain Definitions	  	 	1	  
			
	 SECTION 2
	  	REGISTRATION RIGHTS	  	 	4	  
			
	 2.1
	  	Requested Registration	  	 	4	  
			
	 2.2
	  	Company Registration	  	 	6	  
			
	 2.3
	  	Registration on Form S-3	  	 	7	  
			
	 2.4
	  	Expenses of Registration	  	 	8	  
			
	 2.5
	  	Registration Procedures	  	 	9	  
			
	 2.6
	  	Indemnification	  	 	10	  
			
	 2.7
	  	Information by Holder	  	 	12	  
			
	 2.8
	  	Restrictions on Transfer	  	 	12	  
			
	 2.9
	  	Rule 144 Reporting	  	 	14	  
			
	 2.10
	  	Market Stand-Off Agreement	  	 	15	  
			
	 2.11
	  	Delay of Registration	  	 	15	  
			
	 2.12
	  	Transfer or Assignment of Registration Rights	  	 	15	  
			
	 2.13
	  	Limitations on Subsequent Registration Rights	  	 	15	  
			
	 2.14
	  	Termination of Registration Rights	  	 	16	  
			
	 SECTION 3
	  	CERTAIN COVENANTS OF THE COMPANY	  	 	16	  
			
	 3.1
	  	Basic Financial Information and Inspection Rights	  	 	16	  
			
	 3.2
	  	Confidentiality	  	 	16	  
			
	 3.3
	  	Inspection Rights	  	 	17	  
			
	 3.4
	  	Treatment of Directors	  	 	17	  
			
	 3.5
	  	Termination of Covenants	  	 	17	  
			
	 SECTION 4
	  	RIGHT OF FIRST REFUSAL	  	 	17	  
			
	 4.1
	  	Right of First Refusal to Significant Holders	  	 	17	  
			
	 SECTION 5
	  	MISCELLANEOUS	  	 	18	  
			
	 5.1
	  	Amendment	  	 	18	  
			
	 5.2
	  	Notices	  	 	18	  
			
	 5.3
	  	Governing Law	  	 	19	  
			
	 5.4
	  	Successors and Assigns	  	 	19	  

  
 -i-

 Table of Contents 

(continued) 
  

							
			
		  		  	 	Page	  
	 5.5
	  	Entire Agreement	  	 	19	  
			
	 5.6
	  	Delays or Omissions	  	 	19	  
			
	 5.7
	  	Severability	  	 	20	  
			
	 5.8
	  	Titles and Subtitles	  	 	20	  
			
	 5.9
	  	Execution and Delivery	  	 	20	  
			
	 5.10
	  	Jurisdiction; Venue	  	 	20	  
			
	 5.11
	  	Further Assurances	  	 	21	  
			
	 5.12
	  	Termination Upon Change of Control	  	 	21	  
			
	 5.13
	  	Conflict	  	 	21	  
			
	 5.14
	  	Counterparts	  	 	21	  
			
	 5.15
	  	Aggregation of Stock	  	 	21	  

  
 -ii-

 SOLAZYME, INC. 

THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

This Third Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of
May 19, 2010, by and among Solazyme, Inc., a Delaware corporation (the “Company”), the holders of the Series A Preferred Stock of the Company listed on Exhibit A (“Series A
Investors”), the holders of Series B Preferred Stock of the Company listed on Exhibit A (“Series B Investors”), the holders of Series C Preferred Stock of the Company listed on Exhibit A
(“Series C Investors”) and the holders of Series D Preferred Stock of the Company listed on Exhibit A (“Series D Investors”). The Series A Investors, the Series B Investors, the Series C
Investors and the Series D Investors are sometimes, individually, referred to as an “Investor” and, collectively, as the “Investors.” Unless otherwise defined herein, capitalized terms used in this
Agreement have the meanings ascribed to them in Section 1. 
 RECITALS 

WHEREAS, the Series D Investors are parties to the Series D Preferred Stock
Purchase Agreement of even date herewith, among the Company and the Series D Investors (the “Purchase Agreement”), and it is a condition to the closing of the sale of the Series D Preferred Stock contemplated in the
Purchase Agreement that the Series D Investors and the Company execute and deliver this Agreement. 

WHEREAS, the Company, the Series A Investors, the Series B Investors and the
Series C Investors are parties to that certain Second Amended and Restated Investors’ Rights Agreement, dated as of July 31, 2008 (the “Original Agreement”). 

WHEREAS, the Company, the Series A Investors, the Series B Investors and the
Series C Investors mutually desire to amend and restate the Original Agreement in its entirety as set forth in this Agreement. 
 NOW, THEREFORE: In consideration of the mutual promises and covenants set forth herein, and other consideration, the receipt and adequacy of which is hereby
acknowledged, the parties hereto agree as follows: 
 SECTION 1 

DEFINITIONS 
 1.1 Certain Definitions. As used in this Agreement, the following terms shall have the meanings set forth below: 

(a) “Affiliate” shall mean, with respect to any specified person or entity, any other
person or entity that controls, is controlled by or is under common control with such specified person or entity, or any “immediate family member” (as that term is defined in the Company’s Bylaws) of such specified person or entity,
or any estate of or trust for the benefit of any such immediate family member. 

  
 1 

 (b) “Commission” shall mean the Securities
and Exchange Commission or any other federal agency at the time administering the Securities Act. 
 (c)
“Common Stock” shall mean the Common Stock of the Company. 
 (d)
“Conversion Stock” shall mean shares of Common Stock issued or issuable pursuant to the conversion of the Series A Preferred Stock, the Series B Preferred Stock. the Series C Preferred Stock or the Series D
Preferred Stock. 
 (e) “Exchange Act” shall mean the Securities Exchange Act of
1934, as amended, or any similar successor federal statute and the rules and regulations thereunder, all as the same shall be in effect from time to time. 
 (f) “Holder” shall mean any Investor who holds Registrable Securities and any holder of Registrable Securities to whom the registration rights conferred by this Agreement
have been duly and validly transferred in accordance with Section 2.12 of this Agreement. 
 (g)
“Indemnified Party” shall have the meaning set forth in Section 2.6(c) hereto. 
 (h) “Indemnifying Party” shall have the meaning set forth in Section 2.6(c) hereto. 

(i) “Initial Closing” shall mean the date of the initial sale of shares of
Series D Preferred Stock pursuant to the Purchase Agreement. 
 (j) “Initial Public
Offering” shall mean the closing of the Company’s first firm commitment underwritten public offering of Common Stock registered under the Securities Act. 

(k) “Initiating Holders” shall mean any Holder or Holders who in the aggregate hold at
least fifty percent (50%) of the then-outstanding Registrable Securities and who properly initiate a registration request under this Agreement. 
 (l) “New Securities” shall have the meaning set forth in Section 4.1(a) hereof. 

(m) “Other Selling Stockholders” shall mean persons other than Holders who, by virtue of
agreements with the Company, are entitled to include their Other Shares in certain registrations hereunder. 

(n) “Other Shares” shall mean shares of the Common Stock, other than Registrable
Securities (as defined below), with respect to which registration rights have been granted. 
 (o)
“Preferred Stock” shall mean shares of Series A Preferred Stock, shares of Series B Preferred Stock, shares of Series C Preferred Stock and shares of Series D Preferred Stock of the Company. 

  
 2 

 (p) “Qualified IPO” shall mean the closing of
the Company’s Initial Public Offering with aggregate proceeds of at least $70 million (before deduction of underwriters’ commissions and expenses) and a per share offering price of at least $11.5115 (subject to appropriate adjustment in
the event of a stock split, stock dividend, combination, reclassification, or similar event affecting the Registrable Securities). 
 (q) “Registrable Securities” shall mean (i) Conversion Stock and (ii) any Common Stock issued as a dividend or other distribution with respect to or in exchange
for or in replacement of shares of Conversion Stock; provided, however, that Registrable Securities shall not include any shares of Common Stock described in clause (i) or (ii) above which have previously been registered or which
have been sold to the public either pursuant to a registration statement or Rule 144, or which have been sold in a private transaction in which the transferor’s rights under this Agreement are not validly assigned in accordance with this
Agreement. 
 (r) The terms “register,” “registered” and
“registration” shall refer to a registration effected by preparing and filing a registration statement in compliance with the Securities Act and applicable rules and regulations thereunder, and the declaration or ordering of
the effectiveness of such registration statement. 
 (s) “Registration Expenses”
shall mean all expenses incurred in effecting any registration pursuant to this Agreement, including, without limitation, all registration, qualification, and filing fees, printing expenses, escrow fees, fees and disbursements of counsel for the
Company, blue sky fees and expenses, expenses of any regular or special audits incident to or required by any such registration, and fees and disbursements of one special counsel for the Holders, but shall not include Selling Expenses. 

(t) “Restricted Securities” shall mean any Registrable Securities required to bear the
first legend set forth in Section 2.8(c) hereof. 
 (u)
“Rule 144” shall mean Rule 144 as promulgated by the Commission under the Securities Act, as such Rule may be amended from time to time, or any similar successor rule that may be promulgated by the Commission.

 (v) “Rule 145” shall mean Rule 145 as promulgated by the Commission under
the Securities Act, as such Rule may be amended from time to time, or any similar successor rule that may be promulgated by the Commission. 
 (w) “Securities Act” shall mean the Securities Act of 1933, as amended, or any similar successor federal statute and the rules and regulations thereunder, all as the same
shall be in effect from time to time. 
 (x) “Selling Expenses” shall mean all
underwriting discounts, selling commissions and stock transfer taxes applicable to the sale of Registrable Securities. 
 (y) “Series A Preferred Stock” shall mean the shares of Series A Preferred Stock of the Company. 

  
 3 

 (z) “Series B Preferred Stock” shall mean the
shares of Series B Preferred Stock of the Company. 
 (aa) “Series C Preferred
Stock” shall mean the shares of Series C Preferred Stock of the Company. 
 (bb)
“Series D Preferred Stock” shall mean the shares of Series D Preferred Stock of the Company issued pursuant to the Purchase Agreement. 

(cc) “Significant Holder” shall mean a Holder of at least 1,000,000 shares of Registrable
Securities or 2,000,000 shares of Common Stock (subject in either case to appropriate adjustment in the event of a stock split, stock dividend, combination, reclassification, or similar event affecting the Registrable Securities). 

SECTION 2 
 REGISTRATION RIGHTS 
 2.1 Requested Registration.

 (a) Request for Registration. Subject to the conditions set forth in this Section 2.1,
if the Company shall receive from Initiating Holders a written request signed by such Initiating Holders that the Company effect any registration with respect to all or a part of the Registrable Securities and such request states the number of
shares of Registrable Securities to be disposed of and the intended methods of disposition of such shares by such Initiating Holders, and if the Initiating Holders, together with the Other Selling Stockholders, propose to sell in such registration
Registrable Securities and Other Shares for aggregate proceeds (prior to deduction for underwriter’s discounts and expenses related to the issuance) of $5,000,000 or more , then the Company will: 

(i) promptly give written notice of the proposed registration to all other Holders; and 

(ii) as soon as practicable, file and use its reasonable best efforts to effect such registration (including,
without limitation, filing post-effective amendments, appropriate qualifications under applicable blue sky or other state securities laws, and appropriate compliance with the Securities Act) and to permit or facilitate the sale and distribution of
all or such portion of such Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities of any Holder or Holders joining in such request as are specified in a written request received by
the Company within twenty (20) days after such written notice from the Company is mailed or delivered. 

(b) Limitations on Requested Registration. The Company shall not be obligated to effect, or to take any action to
effect, any such registration pursuant to this Section 2.1: 

  
 4 

 (i) Prior to the earlier of (A) the five (5) year
anniversary of the date hereof or (B) one hundred eighty (180) days following the effective date of its Initial Public Offering; 
 (ii) In any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting such registration, qualification, or compliance, unless
the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; 
 (iii) After the Company has initiated two (2) such registrations pursuant to this Section 2.1; 

(iv) During the period starting with the date sixty (60) days prior to the Company’s good faith
estimate of the date of filing of, and ending on a date ninety (90) days after the effective date of, a registration of Company securities; or 
 (v) If the Initiating Holders propose to dispose of shares of Registrable Securities which may be immediately registered on Form S-3 pursuant to a request made under Section 2.3 hereof.

 (c) Deferral. If (i) in the good faith judgment of the Board of Directors of the Company, the
filing of a registration statement covering the Registrable Securities would be detrimental to the Company and the Board of Directors of the Company concludes, as a result, that it is in the best interests of the Company to defer the filing of such
registration statement at such time, and (ii) the Company shall furnish to such Holders a certificate signed by the Chief Executive Officer of the Company stating that in the good faith judgment of the Board of Directors of the Company, it
would be detrimental to the Company for such registration statement to be filed in the near future and that it is, therefore, in the best interests of the Company to defer the filing of such registration statement, then (in addition to the
limitations set forth in Section 2.1(b)(iv) above) the Company shall have the right to defer such filing for a period of not more than sixty (60) days after receipt of the request of the Initiating Holders, and, provided further,
that the Company shall not defer its obligation in this manner more than once in any twelve-month period. 

(d) Other Shares. The registration statement filed pursuant to the request of the Initiating Holders may, subject
to the provisions of Section 2.1(e), include Other Shares, and may include securities of the Company being sold for the account of the Company. 
 (e) Underwriting. If the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their
request made pursuant to this Section 2.1 and the Company shall include such information in the notice given pursuant to Section 2.1(a)(i). In such event, the right of any Holder to include all or any portion of its
Registrable Securities in such registration pursuant to this Section 2.1 shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities to the extent
provided herein. If the Company shall request inclusion in any registration pursuant to Section 2.1 of securities being sold for its own account, or if Other Selling Stockholders shall request inclusion

  
 5 

 
in any registration pursuant to Section 2.1, the Initiating Holders shall, on behalf of all Holders, offer to include such securities in the underwriting and such offer shall be
conditioned upon the participation of the Company or such Other Selling Stockholders in such underwriting and upon their acceptance of the further applicable provisions of this Section 2 (including Section 2.10). The Company
shall (together with all Holders and other persons proposing to distribute their securities through such underwriting) enter into an underwriting agreement in customary form with the representative of the underwriter or underwriters selected for
such underwriting by the Company which underwriter or underwriters are reasonably acceptable to a majority in interest of the Initiating Holders. 
 Notwithstanding any other provision of this Section 2.1, if the underwriters advise the Initiating Holders in writing that marketing factors require a limitation on the number of shares to be
underwritten, the number of Registrable Securities, Other Shares and shares proposed to be sold for the Company’s account that may be so included shall be allocated as follows: (i) first, among all Holders requesting to include Registrable
Securities in such registration statement based on the pro rata percentage of Registrable Securities held by such Holders, assuming conversion into shares of Common Stock; and (ii) second, to the Company, which the Company may allocate, at its
discretion, for its own account, or for the account of Other Selling Stockholders, other stockholders or employees of the Company, and (iii) third, to the Other Selling Stockholders based on the pro rata percentage of Other Shares held by such
Other Selling Stockholders, assuming conversion into shares of Common Stock. 
 If a stockholder who has
requested inclusion in such registration as provided above does not agree to the terms of any such underwriting, such stockholder’s securities shall be excluded therefrom by written notice from the Company, the underwriter or the Initiating
Holders. The securities so excluded shall also be withdrawn from registration. Any Registrable Securities or other securities excluded or withdrawn from such underwriting shall also be withdrawn from such registration. If shares are so withdrawn
from the registration and if the number of shares to be included in such registration was previously reduced as a result of marketing factors pursuant to this Section 2.1(e), then the Company shall then offer to all Holders and Other
Selling Stockholders who have retained rights to include securities in the registration the right to include additional Registrable Securities or Other Shares in the registration in an aggregate amount equal to the number of shares so withdrawn,
with such shares to be allocated first among such Holders and second to Other Selling Stockholders requesting additional inclusion. 
 2.2 Company Registration. 
 (a) Company Registration.
If the Company shall determine to register any of its securities either for its own account or for the account of a security holder or holders, other than a registration pursuant to Section 2.1 or 2.3, a registration relating to
the Company’s Initial Public Offering, a registration relating solely to employee benefit plans, a registration relating to the offer and sale of debt securities, a registration relating to a corporate reorganization or other Rule 145
transaction, a registration pursuant to a demand request by Other Selling Stockholders; or a registration on any registration form that does not permit secondary sales, the Company will: 

(i) promptly give written notice of the proposed registration to all Holders; and 

  
 6 

 (ii) use its commercially reasonable efforts to include in such
registration (and any related qualification under blue sky laws or other compliance), except as set forth in Section 2.2(b) below, and in any underwriting involved therein, all of such Registrable Securities as are specified in a written
request or requests made by any Holder or Holders received by the Company within ten (10) days after such written notice from the Company is mailed or delivered. Such written request may specify all or a part of a Holder’s Registrable
Securities. 
 (b) Underwriting. If the registration of which the Company gives notice is for a registered public
offering involving an underwriting, the Company shall so advise the Holders in the written notice given pursuant to Section 2.2(a)(i). In such event, the right of any Holder to registration pursuant to this Section 2.2 shall
be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their securities through
such underwriting shall (together with the Company and the Other Selling Stockholders distributing their securities through such underwriting) enter into an underwriting agreement in customary form with the representative of the underwriter or
underwriters selected by the Company. 
 Notwithstanding any other provision of this Section 2.2, if
the underwriters advise the Company in writing that marketing factors require a limitation on the number of shares to be underwritten, the underwriters may (subject to the limitations set forth below) exclude all Registrable Securities from, or
limit the number of Registrable Securities to be included in, the registration and underwriting. The Company shall so advise all holders of securities requesting registration, and the number of shares that are entitled to be included in the
registration and underwriting shall be allocated, as follows: (i) first, to the Company for securities being sold for its own account, (ii) second, to the Holders requesting to include Registrable Securities in such registration statement
based on the pro rata percentage of Registrable Securities held by such Holders, assuming conversion and (iii) third, to the Other Selling Stockholders requesting to include Other Shares in such registration statement based on the pro rata
percentage of Other Shares held by such Other Selling Stockholders, assuming conversion; provided, however that in no event will the Holders be allocated less than twenty-five percent (25%) of the shares to be included in the
registration. 
 If a stockholder who has requested inclusion in such registration as provided above does not
agree to the terms of any such underwriting, such stockholder’s securities shall also be excluded therefrom by written notice from the Company or the underwriter. The Registrable Securities or other securities so excluded shall also be
withdrawn from registration. Any Registrable Securities or other securities excluded or withdrawn from such underwriting shall also be withdrawn from such registration. If shares are so withdrawn from the registration and if the number of shares of
Registrable Securities to be included in such registration was previously reduced as a result of marketing factors pursuant to Section 2.2(b), the Company shall then offer to all persons who have retained the right to include securities
in the registration the right to include additional securities in the registration in an aggregate amount equal to the number of shares so withdrawn, with such shares to be allocated among the persons requesting additional inclusion, in the manner
set forth above. 

  
 7 

 (c) Right to Terminate Registration. The Company shall have the right
to terminate or withdraw any registration initiated by it under this Section 2.2 prior to the effectiveness of such registration whether or not any Holder has elected to include securities in such registration. 

2.3 Registration on Form S-3. 

(a) Request for Form S-3 Registration. After its Initial Public Offering, the Company shall use its commercially
reasonable efforts to qualify for registration on Form S-3 or any comparable or successor form or forms. After the Company has qualified for the use of Form S-3, in addition to the rights contained in the foregoing provisions of this
Section 2 and subject to the conditions set forth in this Section 2.3, if the Company shall receive from a Holder or Holders of at least five percent (5%) of the Registrable Securities a written request that the Company
effect any registration on Form S-3 or any similar short form registration statement with respect to all or part of the Registrable Securities (such request shall state the number of shares of Registrable Securities to be disposed of and the
intended methods of disposition of such shares by such Holder or Holders), the Company will take all such action with respect to such Registrable Securities as required by Section 2.1(a)(i) and (ii). 

(b) Limitations on Form S-3 Registration. The Company shall not be obligated to effect, or take any action to
effect, any such registration pursuant to this Section 2.3: 
 (i) In the circumstances
described in either 2.1(b)(ii) or 2.1(b)(iv); 
 (ii) If the Holders propose to sell
Registrable Securities on Form S-3 at an aggregate price to the public of less than $l,000,000; 
 (iii)
If, in the twelve (12) month period preceding such request, the Company has already effected two (2) such registrations; or 
 (iv) After the Company has initiated three (3) such registrations pursuant to this Section 2.3. 

(c) Deferral. The provisions of Section 2.1(c) shall apply to any registration pursuant to this
Section 2.3. 
 (d) Underwriting. If the Holders of Registrable Securities requesting
registration under this Section 2.3 intend to distribute the Registrable Securities covered by their request by means of an underwriting, the provisions of Sections 2.1(e) shall apply to such registration. Notwithstanding
anything contained herein to the contrary, registrations effected pursuant to this Section 2.3 shall not be counted as requests for registration or registrations effected pursuant to Section 2.1. 

2.4 Expenses of Registration. All Registration Expenses incurred in connection with registrations pursuant to
Sections 2.1, 2.2 and 2.3 hereof shall be borne by the Company; provided, however, that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Sections
2.1 and 2.3 if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities 

  
 8 

 
to be registered or because a sufficient number of Holders shall have withdrawn so that the minimum offering conditions set forth in Sections 2.1 and 2.3 are no longer satisfied (in
which case all participating Holders shall bear such expenses pro rata among each other based on the number of Registrable Securities initially requested to be so registered), unless the Holders of a majority of the Registrable Securities agree to
forfeit their right to a demand registration pursuant to Section 2.1; provided, however, that if a withdrawal by the Holders is based upon material adverse information relating to the Company that is different from the
information known or available (upon request from the Company or otherwise) to the Holders requesting registration at the time of their request for registration under Section 2.1, such registration shall not be treated as a counted
registration for purposes of Section 2.1(b)(iii) hereof, regardless of whether or not the Holders bear the Registration Expenses for such registration. All Selling Expenses relating to securities registered on behalf of the Holders shall
be borne by the holders of securities included in such registration pro rata among each other on the basis of the number of Registrable Securities so registered. 

2.5 Registration Procedures. In the case of each registration effected by the Company pursuant to
Section 2, the Company will keep each Holder advised in writing as to the initiation of each registration and as to the completion thereof. At its expense, the Company will use its commercially reasonable efforts to: 

(a) Keep such registration effective for a period ending on the earlier of the date which is ninety (90) days
from the effective date of the registration statement and such time as the Holder or Holders have completed the distribution described in the registration statement relating thereto; provided, however, that such ninety (90) day
period shall be extended for a period of time equal to the period the Holder(s) and Other Selling Stockholders refrain from selling any securities included in such registration at the request of an underwriter of Common Stock (or other securities)
of the Company. 
 (b) Prepare and file with the Commission such amendments and supplements to such
registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration
statement for the period set forth in subsection (a) above; 
 (c) Furnish such number of
prospectuses, including any preliminary prospectuses, and other documents incident thereto, including any amendment of or supplement to the prospectus, as a Holder from time to time may reasonably request; 

(d) Use its reasonable best efforts to register and qualify the securities covered by such registration statement
under such other securities or Blue Sky laws of such jurisdiction as shall be reasonably requested by the Holders; provided, that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or
to file a general consent to service of process in any such states or jurisdictions. 
 (e) Notify each
seller of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event of which it becomes aware, as a result of which
the 

  
 9 

 
prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary
to make the statements therein not misleading or incomplete in light of the circumstances then existing, and following such notification promptly prepare and furnish to such seller a reasonable number of copies of a supplement to or an amendment of
such prospectus as may be necessary so that, as thereafter delivered to the purchasers of such shares, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading or incomplete in light of the circumstances then existing; 
 (f) Provide a transfer agent and registrar for all Registrable Securities registered pursuant to such registration statement and a CUSIP number for all such Registrable Securities, in each case not
later than the effective date of such registration; 
 (g) Cause all such Registrable Securities
registered pursuant hereunder to be listed on each securities exchange on which similar securities issued by the Company are then listed; 
 (h) Upon a request by the underwriters, use commercially reasonable efforts to furnish, at the closing of the underwriting, if such securities are being sold through underwriters, (i) an
opinion, dated as of the closing, of Company counsel, in form and substance as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters, and (ii) a “comfort” letter dated as of the
closing, from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters;

 (i) Otherwise use commercially reasonable efforts to comply with applicable rules and regulations of
the SEC, and make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months, but not more than eighteen (18) months, beginning with the first month after
the effective date of the Registration Statement, satisfying the provisions of Section 11(a) of the Securities Act; and 
 (j) In connection with any underwritten offering pursuant to a registration statement filed pursuant to Section 2.1 hereof, enter into an underwriting agreement in form reasonably
necessary to effect the offer and sale of Common Stock, provided such underwriting agreement contains reasonable and customary provisions, and provided further, that each Holder participating in such underwriting shall also enter into and perform
its obligations under such an agreement. 
 2.6 Indemnification. 

(a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, each of its officers,
directors and partners, legal counsel, and accountants and each person controlling such Holder within the meaning of Section 15 of the Securities Act, with respect to which registration, qualification, or compliance has been effected pursuant
to this Section 2, and each underwriter, if any, and each person who controls within the meaning of 

  
 10 

 
Section 15 of the Securities Act any underwriter, against all expenses, claims, losses, damages, and liabilities (or actions, proceedings, or settlements in respect thereof) arising out of
or based on: (i) any untrue statement (or alleged untrue statement) of a material fact contained or incorporated by reference in any prospectus, offering circular, or other document (including any related registration statement, notification,
or the like) incident to any such registration, qualification, or compliance, (ii) any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or
(iii) any violation (or alleged violation) by the Company of the Securities Act, any state securities laws or any rule or regulation thereunder applicable to the Company and relating to action or inaction required of the Company in connection
with any offering covered by such registration, qualification, or compliance, and the Company will reimburse each such Holder, each of its officers, directors, partners, legal counsel, and accountants and each person controlling such Holder, each
such underwriter, and each person who controls any such underwriter, for any legal and any other expenses reasonably incurred in connection with investigating and defending or settling any such claim, loss, damage, liability, or action;
provided that the Company will not be liable in any such case to the extent that any such claim, loss, damage, liability, or action arises out of or is based on any untrue statement or omission based upon written information furnished to the
Company by such Holder, any of such Holder’s officers, directors, partners, legal counsel or accountants, any person controlling such Holder, such underwriter or any person who controls any such underwriter and stated to be specifically for use
therein; and provided, further that, the indemnity agreement contained in this Section 2.6(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability, or action if such settlement is
effected without the consent of the Company (which consent shall not be unreasonably withheld). 
 (b) To
the extent permitted by law, each Holder will, if Registrable Securities held by such Holder are included in the securities as to which such registration, qualification, or compliance is being effected, indemnify and hold harmless the Company, each
of its directors, officers, partners, legal counsel, and accountants and each underwriter, if any, of the Company’s securities covered by such a registration statement, each person who controls the Company or such underwriter within the meaning
of Section 15 of the Securities Act, each other such Holder, and each of their officers, directors, and partners, and each person controlling such Holder, against all claims, losses, damages and liabilities (or actions in respect thereof)
arising out of or based on: (i) any untrue statement (or alleged untrue statement) of a material fact contained or incorporated by reference in any such registration statement, prospectus, offering circular, or other document, or (ii) any
omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse the Company and such Holders, directors, officers, partners, legal counsel,
and accountants, persons, underwriters, or control persons for any legal or any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage, liability, or action, in each case to the extent, but only
to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such registration statement, prospectus, offering circular, or other document in reliance upon and in conformity with written
information furnished to the Company by such Holder and stated to be specifically for use therein; provided, however, that the obligations of such Holder hereunder shall not apply to amounts paid in settlement of any such claims,
losses, damages, or liabilities (or actions in respect thereof) if such settlement is effected without the consent of such Holder (which consent 

  
 11 

 
shall not be unreasonably withheld); and provided that in no event shall any indemnity under this Section 2.6 exceed the gross proceeds from the offering received by such
Holder. 
 (c) Each party entitled to indemnification under this Section 2.6 (the
“Indemnified Party”) shall give notice to the party required to provide indemnification (the “Indemnifying Party”) promptly after such Indemnified Party has actual knowledge of any claim as to which indemnity may be
sought, and shall permit the Indemnifying Party to assume the defense of such claim or any litigation resulting therefrom; provided that counsel for the Indemnifying Party, who shall conduct the defense of such claim or any litigation
resulting therefrom, shall be approved by the Indemnified Party (whose approval shall not be unreasonably withheld), and the Indemnified Party may participate in such defense at such party’s expense; and provided further that the failure
of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Section 2.6, to the extent such failure is not prejudicial. No Indemnifying Party, in the defense of any
such claim or litigation, shall, except with the consent of each Indemnified Party, consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such
Indemnified Party of a release from all liability in respect to such claim or litigation. Each Indemnified Party shall furnish such information regarding itself or the claim in question as an Indemnifying Party may reasonably request in writing and
as shall be reasonably required in connection with defense of such claim and litigation resulting therefrom. 

(d) If the indemnification provided for in this Section 2.6 is held by a court of competent
jurisdiction to be unavailable to an Indemnified Party with respect to any loss, liability, claim, damage, or expense referred to herein, then the Indemnifying Party, in lieu of indemnifying such Indemnified Party hereunder, shall contribute to the
amount paid or payable by such Indemnified Party as a result of such loss, liability, claim, damage, or expense in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party on the one hand and of the Indemnified Party
on the other in connection with the statements or omissions that resulted in such loss, liability, claim, damage, or expense as well as any other relevant equitable considerations. The relative fault of the Indemnifying Party and of the Indemnified
Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the Indemnifying Party or by the Indemnified
Party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission. 
 (e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten
public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 
 2.7 Information by Holder. Each Holder of Registrable Securities shall furnish to the Company such information regarding such Holder and the distribution proposed by such Holder as the Company may
reasonably request in writing and as shall be reasonably required in connection with any registration, qualification, or compliance referred to in this Section 2. 

  
 12 

 2.8 Restrictions on Transfer. 

(a) Each Holder and the holder of each certificate representing Registrable Securities by acceptance thereof agrees
to comply in all respects with the provisions of this Section 2.8. Each Holder agrees not to make any sale, assignment, transfer, pledge or other disposition of all or any portion of such Holder’s Restricted Securities, or any
beneficial interest therein, unless and until (x) the transferee thereof has agreed in writing for the benefit of the Company to take and hold such Restricted Securities subject to, and to be bound by, the terms and conditions set forth in this
Agreement, including, without limitation, this Section 2.8 and Section 2.10, (y) except for transfers permitted under Section 2.8(b), the Right of First Refusal in the Company’s Bylaws has been complied
with and (z): 
 (i) There is then in effect a registration statement under the Securities Act covering
such proposed disposition and such disposition is made in accordance with such registration statement; or 

(ii) Such Holder shall have given prior written notice to the Company of such Holder’s intention to make
such disposition and shall have furnished the Company with a detailed description of the manner and circumstances of the proposed disposition, and, if requested by the Company, such Holder shall have furnished the Company, at such Holder’s
expense, (i) an opinion of counsel, reasonably satisfactory to the Company, to the effect that such disposition will not require registration of such Restricted Securities under the Securities Act or (ii) a “no action” letter
from the Commission to the effect that the transfer of such securities without registration will not result in a recommendation by the staff of the Commission that action be taken with respect thereto, whereupon the holder of such Restricted
Securities shall be entitled to transfer such Restricted Securities in accordance with the terms of the notice delivered by the Holder to the Company. 
 (b) Permitted transfers are: (i) a transfer not involving a change in beneficial ownership; (ii) transactions involving the distribution or sale of Restricted Securities by any Holder to
(x) an Affiliate of such Holder, or (y) the distribution of Restricted Securities to any of Holder’s partners, members or other equity owners, or retired partners, retired members or other equity owners, or to the estate of or trusts
for the benefit of any of its partners, members or other equity owners or retired partners, retired members or other equity owners, in accordance with their interests therein; or (iii) transfers in compliance with Rule 144, as long as the
Company is furnished with satisfactory evidence of compliance with such Rule; provided, in each case, that the Holder thereof shall give written notice to the Company of such Holder’s intention to effect such disposition and shall have
furnished the Company with a detailed description of the manner and circumstances of the proposed disposition. For the avoidance of doubt, the Company irrevocably waives its Right of First Refusal under Article XIV of the Company’s Bylaws as
such rights relate to any transfer by a Holder that is a “permitted transfer” under this Section 2.8(b). 
 (c) Each certificate representing Registrable Securities shall (unless otherwise permitted by the provisions of this Agreement) be stamped or otherwise imprinted with a legend substantially similar
to the following (in addition to any legend required under applicable state securities laws): 

  
 13 

 THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE
STATE SECURITIES LAWS PURSUANT TO REGISTRATION OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH
THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT
TO RESTRICTIONS ON TRANSFERABILITY AND RESALE, INCLUDING A LOCKUP PERIOD OF UP TO 180 DAYS IN THE EVENT OF A PUBLIC OFFERING, AS SET FORTH IN AN INVESTORS’ RIGHTS AGREEMENT, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE
COMPANY. 
 The Holders consent to the Company making a notation on its records and giving instructions to any
transfer agent of the Restricted Securities in order to implement the restrictions on transfer established in this Section 2.8. 
 (d) The first legend referring to federal and state securities laws identified in Section 2.8(c) hereof stamped on a certificate evidencing the Restricted Securities and the stock
transfer instructions and record notations with respect to such Restricted Securities shall be removed and the Company shall issue a certificate without such legend to the holder of such Restricted Securities if (i) such securities are
registered under the Securities Act, or (ii) such holder provides the Company with an opinion of counsel reasonably acceptable to the Company to the effect that a proposed public sale or transfer of such securities may be made without
registration under the Securities Act. 
 2.9 Rule 144 Reporting. With a view to making available
the benefits of certain rules and regulations of the Commission that may permit the sale of the Restricted Securities to the public without registration, the Company agrees to use its commercially reasonable efforts to: 

(a) Make and keep public information regarding the Company available as those terms are understood and defined in
Rule 144 under the Securities Act, at all times from and after ninety (90) days following the effective date of the first registration under the Securities Act filed by the Company for an offering of its securities to the general public;

 (b) File with the Commission in a timely manner all reports and other documents required of the
Company under the Securities Act and the Exchange Act at any time after it has become subject to such reporting requirements; and 

  
 14 

 (c) So long as a Holder owns any Restricted Securities, furnish to
the Holder forthwith upon written request a written statement by the Company as to its compliance with the reporting requirements of Rule 144 (at any time from and after ninety (90) days following the effective date of the first
registration statement filed by the Company for an offering of its securities to the general public), and of the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements), a copy of the most recent
annual or quarterly report of the Company, and such other reports and documents so filed as a Holder may reasonably request in availing itself of any rule or regulation of the Commission allowing a Holder to sell any such securities without
registration. 
 2.10 Market Stand-Off Agreement. Each Holder agrees, in connection with the Initial
Public Offering, upon request of the Company or the underwriters managing such offering, not to sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any of the Company’s securities (other than those
included in the registration) without the prior written consent of the Company or such underwriters, as the case may be, for such period of time (not to exceed one hundred eighty (180) days) from the effective date of such registration as may
be requested by the underwriters; provided however that such one hundred eighty (180) day period may be extended to the extent necessary to permit any managing underwriter to comply with NASD Rule 2711(f)(4) or similar rule. The Company may
impose stop-transfer instructions and may stamp each such certificate with the second legend set forth in Section 2.8(c) hereof with respect to the shares of Common Stock (or other securities) subject to the foregoing restriction until
the end of such one hundred eighty (180) day period (as it may be extended pursuant to the proviso above). Each Holder agrees to execute a market standoff agreement with said underwriters in customary form consistent with the provisions of this
Section 2.10. 
 2.11 Delay of Registration. No Holder shall have any right to take any
action to restrain, enjoin, or otherwise delay any registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.12 Transfer or Assignment of Registration Rights. The rights to cause the Company to register securities granted
to a Holder by the Company under this Section 2 may be transferred or assigned by a Holder only to (i) an Affiliate of such Holder or (ii) a transferee or assignee of not less than 100,000 shares of Registrable Securities (as
presently constituted and subject to subsequent adjustments for stock splits, stock dividends, reverse stock splits, and the like); provided that such transfer or assignment of Registrable Securities is effected in accordance with the terms
of Section 2.8 hereof, the Right of First Refusal and Co-Sale Agreement entered into of even date herewith, and applicable securities laws. 
 2.13 Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the Company shall not, without the prior written consent of Holders holding a majority of the
Registered Securities, enter into any agreement with any holder or prospective holder of any securities of the Company giving such holder or prospective holder any registration rights the terms of which are pari passu or senior to the registration
rights granted to the Holders hereunder. 

  
 15 

 2.14 Termination of Registration Rights. The right of any Holder to
request registration or inclusion in any registration pursuant to Section 2.1, 2.2 or 2.3 shall terminate on the earlier of (i) such date, on or after the closing of the Company’s Initial Public Offering, on which
all shares of Registrable Securities held or entitled to be held upon conversion by such Holder (x) constitute less than one percent (1%) of the Company’s outstanding Common Stock and (y) may be sold under Rule 144, and
(ii) three (3) years after the closing of the Initial Public Offering. 
 SECTION 3 

CERTAIN COVENANTS OF THE COMPANY 
 The Company hereby covenants and agrees, as follows: 
 3.1
Basic Financial Information and Inspection Rights. 
 (a) Basic Financial Information. The Company
shall provide to each Significant Holder: 
 (i) Within one hundred eighty (180) days after the end
of each fiscal year of the Company, a consolidated balance sheet of the Company and its subsidiaries, if any, as at the end of such fiscal year, and consolidated statements of income and cash flows of the Company and its subsidiaries, if any, for
such year, prepared in accordance with U.S. generally accepted accounting principles (or any replacement thereof) consistently applied, all such financial statements audited and certified by independent public accountants of nationally recognized
standing selected by the Company. 
 (ii) Within sixty (60) days after the end of each fiscal
quarter of the Company, an unaudited consolidated balance sheet of the Company and its subsidiaries, if any, as of the end of each such quarter, and unaudited consolidated statements of income and cash flows of the Company and its subsidiaries, if
any, for such period, prepared in accordance with U.S. generally accepted accounting principles (or any replacement thereof) consistently applied, subject to changes resulting from normal year-end audit adjustments. 

(iii) Not less than fifteen (15) days prior to the first day of each fiscal year of the Company, an annual
budget for such fiscal year. 
 (b) Inspection Rights. The Company shall permit each Significant Holder,
at such Significant Holder’s expense, to visit and inspect the Company’s properties, to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with its officers during normal business
hours of the Company; provided, that (i) such Significant Holder is required to provide the Company with written notice at least five (5) business days prior to any such requested inspection and (ii) such inspection rights
provided for herein are limited to one (1) occurrence per year; provided, further that such Significant Holder may be excluded from access to any material, records or other information (i) if the Board of Directors determines, in
its reasonable discretion, that such exclusion is reasonably necessary to preserve the attorney-client privilege, (ii) if the Board of Directors determines, in its reasonable discretion, that such exclusion is reasonably necessary to protect
confidential or proprietary information, 

  
 16 

 
(iii) if such Significant Holder is a competitor of the Company, or (iv) if the Company is restricted from making such disclosure pursuant to a bona fide agreement with a third party.

 3.2 Confidentiality. Anything in this Agreement to the contrary notwithstanding, no Holder by reason
of this Agreement shall have access to any trade secrets or classified information of the Company. The Company shall not be required to comply with any information rights of Section 3 in respect of any Holder whom the Company reasonably
determines to be a competitor or an officer, employee, director or holder of more than ten percent (10%) of a competitor. Each Holder acknowledges that the information received by them pursuant to this Agreement may be confidential and for its
use only, and it will not use such confidential information in violation of applicable laws or reproduce, disclose or disseminate such information to any other person (other than its employees or agents having a need to know the contents of such
information, and its attorneys), except in connection with the exercise of rights under this Agreement, unless the Company has made such information available to the public generally or such Holder is required to disclose such information by a
governmental authority. 
 3.3 [Intentionally deleted] 

3.4 Treatment of Directors. Members of the Board of Directors designated by the Holders or any Holder shall be
entitled to receive such expense reimbursement and other similar rights as are accorded to other non-employee members of the Board of Directors including, without limitation, reasonable expense reimbursement related to membership on the Board, and
subject to Section 3.2, access to Company information and Company management. 
 3.5 Observer
Rights. The Company shall invite one representative of each of Braemar Energy Ventures II, LP (“Braemar”), Lightspeed Venture Partners (“Lightspeed”) and The Roda Group
(“Roda”) to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to
its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so
provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if the Company in good faith believes that access to such information or
attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel, result in disclosure of trade secrets or a conflict of interest, or that such Investor or its representative is a competitor of the
Company. Without limiting the generality of the foregoing, no representative under this Section 3.5 may disclose to any person (including a partner, member or shareholder of Braemar, Lightspeed or Roda, as the case may be) who is either
a board member or board observer of a competitor of the Company (as determined by the Company) any proprietary or confidential information provided by the Company to such representative. In addition, no representative under this
Section 3.5 may be a board member or board observer of a competitor of the Company. Notwithstanding the provisions of Section 3.6, the Company’s obligation to any Holder pursuant to this Section 3.5 shall
terminate upon the earlier of (i) the date of the closing of the Qualified IPO and (ii) the date on which such Holder no longer holds at least fifty 

  
 17 

 
percent (50%) of the shares of Preferred Stock or Common Stock issued upon conversion thereof held by such Holder as of the last Closing under the Purchase Agreement. 

3.6 Termination of Covenants. The covenants set forth in this Section 3 shall terminate and be of no
further force and effect following the closing of the Qualified IPO. 
 SECTION 4 

RIGHT OF FIRST REFUSAL 
 4.1 Right of First Refusal to Significant Holders. Except as provided in Section 4.1(d), the Company hereby grants to each Significant Holder the right of first refusal to purchase all
or a portion of such Holder’s pro rata share of New Securities (as defined in Section 4.1(a)) which the Company may, from time to time, propose to sell and issue after the date of this Agreement. A Significant Holder’s pro rata
share, for purposes of this right of first refusal, is equal to the ratio of (a) the number of shares of Common Stock (including shares of Common Stock issued or issuable upon conversion of Preferred Stock and any other securities exercisable
or convertible, directly or indirectly into shares of Common Stock) owned by such Significant Holder immediately prior to the issuance of New Securities to (b) the total number of shares of Common Stock (including shares of Common Stock issued
or issuable upon conversion of Preferred Stock and any other securities exercisable or convertible, directly or indirectly into shares of Common Stock) outstanding immediately prior to the issuance of New Securities, less, in the case of clause (b),
the shares of Common Stock issued or issuable directly or indirectly in connection with the issuance of $1,245,000 of convertible subordinated promissory notes issued on April 7, 2008, pursuant to the second closing under that certain Note
Purchase Agreement dated as of March 7, 2008. Each Significant Holder that elects to purchase or acquire its full pro rata share (each, a “Fully Exercising Significant Holder”) shall have a right of over-allotment such
that if any Significant Holder fails to exercise its right hereunder to purchase its full pro rata share of New Securities, each Fully Exercising Significant Holder may purchase up to that portion of New Securities for which Significant Holders were
entitled to subscribe but that were not subscribed for by such Significant Holders which is equal to the ratio of (a) the number of shares of Common Stock (including shares of Common Stock issued or issuable upon conversion of Preferred Stock
and any other securities exercisable or convertible, directly or indirectly into shares of Common Stock) then owned by such Fully Exercising Significant Holder to (b) the number of shares of Common Stock (including shares of Common Stock issued
or issuable upon conversion of Preferred Stock and any other securities exercisable or convertible, directly or indirectly into shares of Common Stock) then owned by all Fully Exercising Significant Holders who wish to purchase such undersubscribed
shares (such option, an “Overallotment Option”). This right of first refusal is subject to the following provisions: 
 (a) “New Securities” shall mean any capital stock (including Common Stock and Preferred Stock) of the Company whether or not now authorized, and rights, convertible securities,
options or warrants to purchase such capital stock, and securities of any type whatsoever that are, or may become, exercisable or convertible into capital stock; provided that the term “New Securities” does not include
(x) “Excluded Securities” as defined in the Company’s Amended and Restated Certificate of Incorporation, as it may be amended from 

  
 18 

 
time to time (the “Certificate of Incorporation”) or (y) any shares of Series D Preferred Stock issued pursuant to the Purchase Agreement. 

(b) In the event the Company proposes to undertake an issuance of New Securities, it shall give each Significant
Holder written notice of its intention, describing the type of New Securities, and their price and the general terms upon which the Company proposes to issue the same. Each Significant Holder shall have twenty (20) days after any such notice is
mailed or delivered to agree to purchase such Holder’s pro rata share of such New Securities and to indicate whether such Holder desires to exercise its Over Allotment Option for the price and upon the terms specified in the notice by giving
written notice to the Company, in substantially the form attached hereto as Schedule 1, and stating therein the quantity of New Securities to be purchased. 

(c) In the event the Holders fail to exercise fully the right of first refusal and over allotment rights, if any,
within said twenty (20) day period (the “Election Period”), the Company shall have ninety (90) days thereafter to sell or enter into an agreement (pursuant to which the sale of New Securities covered thereby shall be
closed, if at all, within ninety (90) days from the date of said agreement) to sell that portion of the New Securities with respect to which the Significant Holders’ right of first refusal option set forth in this Section 4.1
was not exercised, at a price and upon terms no more favorable to the purchasers thereof than specified in the Company’s notice to Significant Holders delivered pursuant to Section 4.1(b). In the event the Company has not sold the
New Securities within such ninety (90) day period following the Election Period, or such ninety (90) day period following the date of said agreement, the Company shall not thereafter issue or sell any New Securities, without first again
offering such securities to the Significant Holders in the manner provided in this Section 4.1. 

(d) The right of first refusal granted under this Section 4.1 shall expire upon, and shall not be
applicable to, a Qualified IPO. 
 SECTION 5 
 MISCELLANEOUS 
 5.1 Amendment. Except as expressly
provided herein, neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument referencing this Agreement and signed by (i) the Company, (ii) Investors holding at least a
majority of the Common Stock issued or issuable upon conversion of the Series A Preferred Stock and Series B Preferred Stock (excluding any of such shares that have been sold to the public or pursuant to Rule 144), taken together as a single class,
(iii) Investors holding at least a majority of the Common Stock issued or issuable upon conversion of the Series C Preferred Stock (excluding any of such shares that have been sold to the public or pursuant to Rule 144), taken as a separate
class, and (iv) Investors holding at least a majority of the Common Stock issued or issuable upon conversion of the Series D Preferred Stock (excluding any of such shares that have been sold to the public or pursuant to Rule 144), taken as a
separate class, (Investors holding sufficient shares of Common Stock to satisfy the requirements of clauses (ii), (iii) and (iv) are referred to herein as the “Requisite Investors”); provided, however, that
Holders purchasing shares of Series D Preferred Stock in a Closing (as defined in the Purchase 

  
 19 

 
Agreement) after the Initial Closing may become parties to this Agreement, by executing a counterpart of this Agreement without any amendment of this Agreement pursuant to this paragraph or any
consent or approval of any other Holder. Any such amendment, waiver, discharge or termination effected in accordance with this paragraph shall be binding upon each Holder and each future holder of all such securities of Holder. The Company shall
give written notice of any amendment, waiver, discharge or termination hereunder to any party hereto that did not consent in writing to such amendment, waiver, discharge or termination. Each Holder acknowledges that by the operation of this
paragraph, the Requisite Investors will have the right and power to diminish or eliminate all rights of such Holder under this Agreement. 
 5.2 Notices. All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered or certified mail, postage prepaid, sent by facsimile or
electronic mail or otherwise delivered by hand or by messenger addressed: 
 (a) if to an Investor, at
the Investor’s address, facsimile number or electronic mail address as shown in the Company’s records, as may be updated in accordance with the provisions hereof; 

(b) if to any Holder, at such address, facsimile number or electronic mail address as shown in the Company’s
records, or, until any such Holder so furnishes an address, facsimile number or electronic mail address to the Company, then to and at the address of the last Holder of such shares for which the Company has contact information in its records; or

 (c) if to the Company, one copy should be sent to 225 Gateway Boulevard, South San Francisco, CA
94080, Attn: Chief Executive Officer, or at such other address as the Company shall have furnished to the Investors, with a copy (which shall not constitute notice) to Howard Lasky, Esq., Coblentz, Patch, Duffy & Bass LLP, One Ferry
Building, Suite 200, San Francisco, California 94111. 
 Each such notice or other communication shall for all
purposes of this Agreement be treated as effective or having been given when delivered if delivered personally, or, if sent by mail, at the earlier of its receipt or seventy two (72) hours after the same has been deposited in a regularly
maintained receptacle for the deposit of the United States mail, addressed and mailed as aforesaid or, if sent by facsimile, upon confirmation of facsimile transfer or, if sent by electronic mail, upon confirmation of delivery when directed to an
electronic mail address provided by the recipient. 
 5.3 Governing Law. This Agreement shall be governed
in all respects by the internal laws of the State of California as applied to agreements entered into among California residents to be performed entirely within California, without regard to principles of conflicts of law. 

5.4 Successors and Assigns. Except as expressly set forth herein, this Agreement, and any and all rights, duties
and obligations hereunder, shall not be assigned, transferred, delegated or sublicensed by any Holder without the prior written consent of the Company. Any attempt without such permission to assign, transfer, delegate or sublicense any rights,
duties or obligations that arise under this Agreement shall be void. Subject to the foregoing and except as 

  
 20 

 
otherwise provided herein, the provisions of this Agreement shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto.

 5.5 Entire Agreement. This Agreement and any exhibits hereto constitute the full and entire
understanding and agreement between the parties with regard to the subjects hereof. Each Investor that is a party to this Agreement hereby waives (on behalf of itself, all of its Affiliates and any assignees or transferees thereof) any right it may
have been granted by the Company prior to the date hereof, in the nature of a right of first refusal, right of first offer, right of participation, or preemptive right, as any such right may have applied to the offer and sale by the Company of any
of its shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock or Series D Preferred Stock. Without limiting the foregoing, this Agreement amends and restates the Original Agreement in its entirety. No party hereto
shall be liable or bound to any other party in any manner with regard to the subjects hereof or thereof by any warranties, representations or covenants except as specifically set forth herein. 

5.6 Delays or Omissions. Except as expressly provided herein, no delay or omission to exercise any right, power or
remedy accruing to any party to this Agreement upon any breach or default of any other party under this Agreement shall impair any such right, power or remedy of such non-defaulting party, nor shall it be construed to be a waiver of any such breach
or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any
waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and
shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party to this Agreement, shall be cumulative and not alternative. 

5.7 Severability. If any provision of this Agreement becomes or is declared by a court of competent jurisdiction
to be illegal, unenforceable or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from this Agreement, and such court will replace such illegal, void or unenforceable provision of this
Agreement with a valid and enforceable provision that will achieve, to the extent possible, the same economic, business and other purposes of the illegal, void or unenforceable provision. The balance of this Agreement shall be enforceable in
accordance with its terms. 
 5.8 Titles and Subtitles. The titles and subtitles used in this Agreement
are used for convenience only and are not to be considered in construing or interpreting this Agreement. All references in this Agreement to sections, paragraphs and exhibits shall, unless otherwise provided, refer to sections and paragraphs hereof
and exhibits attached hereto. 
 5.9 Execution and Delivery. A facsimile or other reproduction of this
Agreement may be executed by one or more parties hereto and delivered by such party by facsimile or any similar electronic transmission device pursuant to which the signature of or on behalf of such party can be seen. Such execution and delivery
shall be considered valid, binding and effective for all purposes. At the request of any party hereto, all parties hereto agree to execute and deliver an original of this Agreement as well as any facsimile or other reproduction hereof. 

  
 21 

 5.10 Jurisdiction; Venue. Any unresolved controversy or claim arising
out of or relating to this Agreement, except as otherwise provided in this Agreement shall be submitted to arbitration by one arbitrator mutually agreed upon by the parties, and if no agreement can be reached within thirty (30) days after names
of potential arbitrators have been proposed by JAMS, then by one arbitrator having reasonable experience in corporate finance transactions who is chosen by JAMS. The arbitration shall take place in the City and County of San Francisco, California,
in accordance with the JAMS Comprehensive Arbitration Rules (or successor rules then in effect), and judgment upon any award rendered in such arbitration will be binding and may be entered in any court having jurisdiction thereof. There shall be
limited discovery prior to the arbitration hearing as follows: (a) exchange of witness lists and copies of documentary evidence and documents relating to or arising out of the issues to be arbitrated, (b) depositions of all party witnesses
and (c) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the California Code of Civil Procedure, the arbitrator shall be required to provide in writing
to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Each party will bear its own costs in respect to any
disputes arising under this Agreement. Each of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U. S. District Court for the Northern District of California or any court of the State of
California having subject matter jurisdiction. 
 5.11 Further Assurances. Each party hereto agrees to
execute and deliver, by the proper exercise of its corporate, limited liability company, partnership or other powers, all such other and additional instruments and documents and do all such other acts and things as may be necessary to more fully
effectuate this Agreement. 
 5.12 Termination Upon Change of Control. Notwithstanding anything to the
contrary herein, this Agreement shall terminate upon (a) the acquisition of the Company by another entity by means of any transaction or series of related transactions to which the Company is party (including, without limitation, any stock
acquisition, reorganization, merger or consolidation but excluding any sale of stock for capital raising purposes) other than a transaction or series of transactions in which the holders of the voting securities of the Company outstanding
immediately prior to such transaction continue to retain (either by such voting securities remaining outstanding or by such voting securities being converted into voting securities of the surviving entity), as a result of shares in the Company held
by such holders prior to such transaction, at least fifty percent (50%) of the total voting power represented by the voting securities of the Corporation or such surviving entity outstanding immediately after such transaction or series of
transactions; or (b) a sale, lease, transfer, exclusive license or other conveyance of all or substantially all of the assets of the Company. 
 5.13 Conflict. In the event of any conflict between the terms of this Agreement and the Certificate of Incorporation, the terms of the Certificate of Incorporation will control. 

5.14 Telecopy Execution and Delivery A facsimile, telecopy or other reproduction of this Agreement may be executed
by one or more parties hereto and delivered by such party by facsimile or any similar electronic transmission device pursuant to which the signature of or on behalf of such party can be seen. Such execution and delivery shall be considered valid,
binding 

  
 22 

 
and effective for all purposes. At the request of any party hereto, all parties hereto agree to execute and deliver an original of this Agreement as well as any facsimile, telecopy or other
reproduction hereof. 
 5.15 Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be enforceable against the parties that execute such counterparts, and all of which together shall constitute one instrument. 
 5.16 Aggregation of Stock. All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for the purpose of determining the availability of any rights under this
Agreement. 
 5.17 Spousal Consent. If, at the time a party to this Agreement executes such Agreement,
the party is (i) married, (ii) a registered domestic partner, or (iii) subject to similar legal rights and obligations granted by local, state, federal or foreign law (the person with whom such party has rights and obligations, a
“Spouse”), such party’s Spouse shall have executed a Consent of Spouse attached to this Agreement as Exhibit B. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 23 

 IN WITNESS WHEREOF, the
parties hereto have executed this Third Amended and Restated Investors’ Rights Agreement effective as of the date first above written. 
  

			
	SOLAZYME, INC.
	a Delaware corporation
		
	By:	 	 /s/ Jonathan S. Wolfson

		
	Name:	 	 Jonathan S. Wolfson

		
	Title:	 	 Chief Executive Officer

  

[SIGNATURE PAGE TO THIRD AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this Third Amended and Restated Investors’ Rights Agreement effective as of the day and year first above written. 
  

			
	INVESTOR:
	
	BRAEMAR ENERGY VENTURES II, LP
		
	By:	 	Braemar Power and Communications Management II, LP, its general partner
		
	By:	 	Braemar Partners, LLC, its general partner
		
	By:	 	 /s/ William D. Lese

		 	William D. Lese, Managing Member

			
	Address:	 	340 Madison Avenue, 18th Floor
		 	New York, NY 10173

			
	Fax:	 	  

	
	SOLAZYME INVESTMENTS, LLC
		
	By:	 	Braemar Energy Ventures II, LP, its Manager
		
	By:	 	Braemar Power and Communications
		 	Management II, LP, its general partner
		
	By:	 	Braemar Partners, LLC, its general partner
		
	By:	 	 /s/ William D. Lese

		 	William D. Lese, Managing Member

			
	Address:	 	340 Madison Avenue, 18th Floor
		 	New York, NY 10173

			
	Fax:	 	  

  

[SIGNATURE PAGE TO THIRD AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this Third Amended and Restated Investors’ Rights Agreement on the date first above written. 
  

			
	INVESTORS:
	
	SAN-EI GEN F.F.I., INC.
		
	By:	 	 /s/ Takashige
Shimizu

			
	Name:	 	Takashige Shimizu, Ph.D.
	Title:	 	Chairman and President

			
	Address:	 	1-1-11, Sanwa-cho, Toyonaka
		 	Osaka, 561-8588, Japan

			
	Fax:	 	  

  

  

[SIGNATURE PAGE TO THIRD AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this Third Amended and Restated Investors’ Rights Agreement on the date first above written. 
  

			
	INVESTORS:
	
	THE RODA GROUP INVESTMENT FUND XX, LLC
		
	By:	 	 /s/ Roger A. Strauch

	Name:	 	Roger A. Strauch
	Title:	 	Managing Member
	Address:	 	 918 Parker Street
 Berkeley,
CA 94710

	Fax:	 	  

	
	THE STRAUCH KULHANJIAN FAMILY TRUST DATED 12/3/92
		
	By:	 	 /s/ Roger A. Strauch

	Name:	 	Roger A. Strauch
	Title:	 	Trustee
	Address:	 	 918 Parker Street
 Berkeley,
CA 94710

	Fax:	 	  

	
	THE DANIEL H. MILLER REVOCABLE TRUST
		
	By:	 	 /s/ Daniel H. Miller

	Name:	 	Daniel H. Miller
	Title:	 	Trustee
	Address:	 	 111 Tappan Lane
 Orinda, CA
94563

	Fax:	 	  

  

  

[SIGNATURE PAGE TO THIRD AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this Third Amended and Restated Investors’ Rights Agreement on the date first above written. 
  

			
	INVESTORS:
	
	ROGER A. STRAUCH
	
	 /s/ Roger Strauch

	Address:	 	 918 Parker Street
 Berkeley,
CA 94710

			
	Fax:	 	  

	
	THE DCM EDUCATIONAL TRUST

			
		
	By:	 	 /s/ Roger
Strauch

			
	Name:	 	Roger Strauch
	Title:	 	Trustee

			
	Address:	 	 918 Parker Street
 Berkeley,
CA 94710

	Fax:	 	  

	
	THE STRAUCH/KULHANJIAN 2007 IRREVOCABLE CHILDREN’S TRUST

			
		
	By:	 	 /s/ Roger
Strauch

			
	Name:	 	Roger Strauch
	Title:	 	Trustee

			
	Address:	 	 918 Parker Street
 Berkeley,
CA 94710

			
	Fax:	 	
 

			
	
	THE COOPER OGDEN MILLER TRUST

			
		
	By:	 	 /s/ Roger
Strauch

			
	Name:	 	Roger Strauch
	Title:	 	Trustee

			
	Address:	 	 918 Parker Street
 Berkeley,
CA 94710

			
	Fax:	 	  

  

[SIGNATURE PAGE TO THIRD AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the parties hereto
have executed this Third Amended and Restated Investors’ Rights Agreement on the date first above written. 
  

			
	INVESTORS:
	
	THE EMMELINE MAEVE MCPHERSON MILLER TRUST

			
		
	By:	 	 /s/ Roger
Strauch

			
	Name:	 	Roger Strauch
	Title:	 	Trustee

			
	Address:	 	 918 Parker Street
 Berkeley,
CA 94710

			
	Fax:	 	
 

			
	
	 THE RODA GROUP INVESTMENT
 FUND XIV, LLC

			
		
	By:	 	 /s/ Roger
Strauch

			
	Name:	 	Roger Strauch
	Title:	 	Managing Member

			
	Address:	 	 918 Parker Street
 Berkeley,
CA 94710

			
	Fax:	 	
 

			
	
	 THE RODA GROUP INVESTMENT
 FUND XV, LLC

			
		
	By:	 	 /s/ Roger
Strauch

			
	Name:	 	Roger Strauch
	Title:	 	Managing Member

			
	Address:	 	 918 Parker Street
 Berkeley,
CA 94710

			
	Fax:	 	  

  

[SIGNATURE PAGE TO THIRD AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this Third Amended and Restated Investors’ Rights Agreement on the date first above written. 
  

			
	INVESTORS:
	
	 THE RODA GROUP INVESTMENT
 FUND XVII, LLC

			
		
	By:	 	 /s/ Roger
Strauch

			
	Name:	 	Roger Strauch
	Title:	 	Managing Member

			
	Address:	 	 918 Parker Street
 Berkeley,
CA 94710

			
	Fax:	 	
 

			
	
	 THE RODA GROUP INVESTMENT
 FUND XVIII, LLC

			
		
	By:	 	 /s/ Roger
Strauch

			
	Name:	 	Roger Strauch
	Title:	 	Managing Member

			
	Address:	 	 918 Parker Street
 Berkeley,
CA 94710

			
	Fax:	 	
 

			
	
	 THE RODA GROUP INVESTMENT
 FUND XIX, LLC

			
		
	By:	 	 /s/ Roger
Strauch

			
	Name:	 	Roger Strauch
	Title:	 	Managing Member

			
	Address:	 	 918 Parker Street
 Berkeley,
CA 94710

			
	Fax:	 	  

  

[SIGNATURE PAGE TO THIRD AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this Third Amended and Restated Investors’ Rights Agreement on the date first above written. 
  

			
	 INVESTORS:
  

LIGHTSPEED VENTURE PARTNERS VII, LP

		
	By:	 	Lightspeed General Partner VII LP,
		 	its general partner:
		
	By:	 	Lightspeed Ultimate General Partner VII, Ltd.,
		 	its general partner

			
		
	By:	 	 /s/ Christopher J.
Schaepe

			
	Name:	 	Christopher J. Schaepe
		 	Duly Authorized Signatory

			
	Address:	 	2200 Sand Hill Road
		 	Menlo Park, CA 94025

			
	Fax:	 	  

  

[SIGNATURE PAGE TO THIRD AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this Third Amended and Restated Investors’ Rights Agreement on the date first above written. 
  

			
	INVESTORS:
	
	JAZEM I FAMILY PARTNERS, LP

			
		
	By:	 	 /s/ Jerry L.
Fiddler

			
	Name:	 	Jerry L. Fiddler
	Title:	 	General Partner

			
	Address:	 	 899 Northgate Drive, Suite 301
 San Rafael, CA 94903

			
	Fax:	 	
 

			
	
	THE FIDDLER AND ALDEN FAMILY TRUST

			
		
	By:	 	 /s/ Jerry L.
Fiddler

			
	Name:	 	Jerry L. Fiddler
	Title:	 	Trustee

			
	Address:	 	 899 Northgate Drive, Suite 301
 San Rafael, CA 94903

			
	Fax:	 	
 

			
	
	JAZEM II FAMILY PARTNERS, LP

			
		
	By:	 	 /s/ Jerry L.
Fiddler

			
	Name:	 	Jerry L. Fiddler
	Title:	 	General Partner

			
	Address:	 	 899 Northgate Drive, Suite 301
 San Rafael, CA 94903

			
	Fax:	 	
 

			
	
	JAZEM IV FAMILY PARTNERS, LP

			
		
	By:	 	 /s/ Jerry L.
Fiddler

			
	Name:	 	Jerry L. Fiddler
	Title:	 	General Partner

			
	Address:	 	 899 Northgate Drive, Suite 301
 San Rafael, CA 94903

			
	Fax:	 	  

  

[SIGNATURE PAGE TO THIRD AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this Third Amended and Restated Investors’ Rights Agreement on the date first above written. 

 

			
	INVESTORS:
	
	HARRIS & HARRIS GROUP, INC.
		
	By:	 	 /s/ Sandra M.
Forman

			
	Name:	 	Sandra M. Forman
	Title:	 	General Counsel

			
	Address:	 	  1450 Broadway, 24th Floor
		 	  New York, NY 10018

			
	Fax:	 	  

  

[SIGNATURE PAGE TO THIRD AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS
WHEREOF, the parties hereto have executed this Third Amended and Restated Investors’ Rights Agreement on the date first above written. 

 

			
	INVESTORS:
	
	SPRING VENTURES, LLC
		
	By:	 	 /s/ Sunil
Paul

			
	Name:	 	Sunil Paul
	Title:	 	Founding Partner

			
	Address:	 	  912 Cole Street #385
		 	  San Francisco, CA 94117
		
	Fax:	 	  

  

[SIGNATURE PAGE TO THIRD AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this Third Amended and Restated Investors’ Rights Agreement on the date first above written. 
  

			
	INVESTORS:
	
	J. SANDLER VENTURE I, LLC
		
	By:	 	 /s/ James
Sandler

			
		 	James Sandler, Manager

			
		
	Address:	 	c/o The Sandler Foundation
		 	Four Embarcadero Center, Suite 3150
		 	San Francisco, California 94111

			
		
	Fax:	 	  

  

[SIGNATURE PAGE TO THIRD AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the
parties hereto have executed this Third Amended and Restated Investors’ Rights Agreement on the date first above written. 
  

			
	INVESTORS:
	
	GARRETT GRUENER
	
	 /s/ Garrett Gruener

	Address:	 	   P.O. Box 5018

  Berkeley, CA 94705

			
		
	Fax:	 	  

  

[SIGNATURE PAGE TO THIRD AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 Schedule 1 

NOTICE AND WAIVER/ELECTION OF 
 RIGHT OF FIRST REFUSAL 
 I do hereby waive or exercise, as indicated
below, my rights of first refusal under the Third Amended and Restated Investors’ Rights Agreement dated as of May 19, 2010 (the “Agreement”): 
  

	1.	Waiver of 20-Day Notice Period in Which to Exercise Right of First Offer: (please check only one) 

 

	 	(  )	WAIVE in full, on behalf of all Holders, the 20-day notice period provided to exercise my right of first refusal granted under the Agreement. 

 

	 	(  )	DO NOT WAIVE the notice period described above. 

  

	2.	Issuance and Sale of New Securities: (please check only one) 

  

	 	(  )	WAIVE in full the right of first refusal granted under the Agreement with respect to the issuance of the New Securities. 

 

	 	(  )	ELECT TO PARTICIPATE in $         [PLEASE PROVIDE AMOUNT] in New Securities proposed to be issued by Solazyme, Inc.,
representing less than my pro rata portion of the New Securities being offered in the financing. 

  

	 	(  )	ELECT TO PARTICIPATE in $         in New Securities proposed to be issued by Solazyme, Inc., representing my full pro
rata portion of the New Securities being offered in the financing. 

  

	 	(  )	ELECT TO PARTICIPATE in my full pro rata portion of the aggregate of $         in New Securities being made available in
the financing and, to the extent available, the greater of: (please check only one) 

  

	 	(  )	an additional $         [PLEASE PROVIDE AMOUNT] or 

 

	 	(  )	my pro rata portion of any remaining investment amount available in the event other Significant Holders do not exercise their full rights of first refusal with respect
to the New Securities being offered in the financing. 

  

							
	Date:             , 20    	 		 		 	  

		 		 		 	Signature of Stockholder or Authorized Signatory
				
		 		 		 	  

		 		 		 	Title, if applicable

 This is
neither a commitment to purchase nor a commitment to issue the New Securities described above. Such issuance can only be made by way of definitive documentation related to such issuance. Solazyme, Inc. will supply you with such definitive
documentation upon request or if you indicate that you would like to exercise your first offer rights in whole or in part. 
 SCHEDULE 1 

 EXHIBIT A 

INVESTORS 
  

																					
	Name and Address	  	Series A
Shares	 	  	Series B
Shares	 	  	Series C
Shares	 	  	Series D
Shares	 	  	Total
Shares	 
	 Bagshaw/Petersmeyer Family Trust

U/A/D 3/25/91
 49 Parker Avenue

Atherton, CA 94027
	  	 	 	 	  	 	 	 	  	 	16,886	  	  	 	 	 	  	 	16,866	  
	 Hilary Petersmeyer Bagshaw Trust

Dtd 9/14/2001
 49 Parker Avenue

Atherton, CA 94027
	  	 	53,129	  	  	 	37,445	  	  	 	 	 	  	 	 	 	  	 	90,574	  
	 Kristin Petersmeyer Bagshaw Trust

Dtd 9/14/2001
 49 Parker Avenue

Atherton, CA 94027
	  	 	53,129	  	  	 	37,445	  	  	 	 	 	  	 	 	 	  	 	90,574	  
	 Molly Petersmeyer Bagshaw Trust

Dtd 9/14/2001
 49 Parker Avenue

Atherton, CA 94027
	  	 	53,129	  	  	 	37,447	  	  	 	 	 	  	 	 	 	  	 	90,576	  
	 Robert Dillon

1500 Kearns Blvd., Suite E302
 Park City,
UT
	  	 	105,334	  	  	 	 	 	  	 	 	 	  	 	 	 	  	 	105,334	  
	 Mary Dillon

1500 Kearns Blvd., Suite E302
 Park City,
UT
	  	 	79,693	  	  	 	 	 	  	 	 	 	  	 	 	 	  	 	79,693	  
	 Charlie Finnie

128 Alvarado Road
 Berkeley, CA
94027
	  	 	159,387	  	  	 	49,525	  	  	 	22,515	  	  	 	 	 	  	 	231,427	  
	 Harris & Harris Group, Inc.

1450 Broadway,
24th Floor

New York, NY 10018
 Attn: Sandra M.
Forman,
 General Counsel
	  	 	988,204	  	  	 	495,246	  	  	 	651,309	  	  	 	169,391	  	  	 	2,304,150	  
	 Randy M. Haykin and Patricia

Haykin Trust
 Randy M. Haykin, Trustee

7908 Paragon Circle
 Pleasanton, CA
94588
	  	 	159,387	  	  	 	 	 	  	 	 	 	  	 	 	 	  	 	159,387	  
	 Richard Neuwirth

c/o Twinlab
 632 Broadway, 11th Fl

New York, NY 10012
	  	 	79,693	  	  	 	 	 	  	 	 	 	  	 	 	 	  	 	79,693	  
	 The Roda Group Investment Fund

XIV, LLC
 The Roda Group

918 Parker Street
 Berkeley, CA
94710
	  	 	1,025,641	  	  	 	3,466,719	  	  	 	872,543	  	  	 	 	 	  	 	5,364,903	  
	The Roda Group Investment Fund XVII, LLC	  	 	512,820	  	  	 	495,246	  	  	 	201,296	  	  	 	 	 	  	 	1,209,362	  

  
 A-2

																					
	Name and Address	  	Series A
Shares	 	  	Series B
Shares	 	  	Series C
Shares	 	  	Series D
Shares	 	  	Total
Shares	 
	 The Roda Group

918 Parker Street
 Berkeley, CA
94710
	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
	 The Daniel H. Miller Revocable Trust

The Roda Group
 918 Parker Street

Berkeley, CA 94710
	  	 	687,663	  	  	 	368,792	  	  	 	93,194	  	  	 	16,939	  	  	 	1,166,588	  
	 The Strauch Kulhanjian Family Trust

dated 12/03/92
 The Roda Group

918 Parker Street
 Berkeley, CA
94710
	  	 	705,127	  	  	 	221,547	  	  	 	93,194	  	  	 	16,939	  	  	 	1,036,807	  
	 The Strauch/Kulhanjian 2007

Irrevocable Children’s Trust
 The Roda
Group
 918 Parker Street
 Berkeley, CA
94710
	  	 	 	 	  	 	297,147	  	  	 	 	 	  	 	 	 	  	 	297,147	  
	 Roger A. Strauch

The Roda Group
 918 Parker Street

Berkeley, CA 94710
	  	 	318,775	  	  	 	 	 	  	 	 	 	  	 	 	 	  	 	318,775	  
	 The DCM Educational Trust

The Roda Group
 918 Parker Street

Berkeley, CA 94710
	  	 	17,464	  	  	 	50,852	  	  	 	 	 	  	 	 	 	  	 	68,316	  
	 The Cooper Ogden Miller Trust

The Roda Group
 918 Parker Street

Berkeley, CA 94710
	  	 	 	 	  	 	49,525	  	  	 	 	 	  	 	 	 	  	 	49,525	  
	 The Emmeline Maeve McPherson Trust

The Roda Group
 918 Parker Street

Berkeley, CA 94710
	  	 	 	 	  	 	49,525	  	  	 	 	 	  	 	 	 	  	 	49,525	  
	 Arbige and Stuart 2004 Trust,

Executed September 23, 2004
 1256 Birch
Street
 Montara, CA 94037
	  	 	 	 	  	 	99,049	  	  	 	 	 	  	 	 	 	  	 	99,049	  
	 Garrett Gruener

P.O. Box 5018
 Berkeley, CA 94705
	  	 	 	 	  	 	148,574	  	  	 	56,290	  	  	 	28,231	  	  	 	233,095	  
	 Peter Kovacs Living Trust U/A

DTD 12/06/90
 930 Tahoe Blvd., #802

Incline Village, NV 89451
	  	 	 	 	  	 	49,524	  	  	 	 	 	  	 	 	 	  	 	49,524	  
	 The Roda Group Investment Fund

XVIII, LLC
 The Roda Group

918 Parker Street
 Berkeley, CA
94710
	  	 	 	 	  	 	2,429,331	  	  	 	 	 	  	 	 	 	  	 	2,429,331	  
	Tevis Partners I	  	 	159,387	  	  	 	 	 	  	 	 	 	  	 	 	 	  	 	159,387	  

  
 A-3

																					
	Name and Address	  	Series A
Shares	 	  	Series B
Shares	 	  	Series C
Shares	 	  	Series D
Shares	 	  	Total
Shares	 
	Richard Slaughter	  	 	318,775	  	  	 	 	 	  	 	 	 	  	 	 	 	  	 	318,775	  
	 Braemar Energy Ventures II, LP

Independence Wharf
 470 Atlantic Avenue, 10th
floor
 Boston, MA 02210
	  	 	 	 	  	 	 	 	  	 	2,481,350	  	  	 	 	 	  	 	2,481,350	  
	 Lightspeed Venture Partners VII, LP

220 Sand Hill Road
 Menlo Park, CA
94025
	  	 	 	 	  	 	 	 	  	 	2,481,350	  	  	 	338,783	  	  	 	2,820,133	  
	 Jazem I Family Partners, LP

899 Northgate Drive, Suite 301
 San Rafael, CA
94903
	  	 	2,269,560	  	  	 	198,098	  	  	 	70,752	  	  	 	169,391	  	  	 	2,707,801	  
	 Jazem II Family Partners, LP

899 Northgate Drive, Suite 301, San
 Rafael, CA
94903
	  	 	 	 	  	 	 	 	  	 	96,077	  	  	 	 	 	  	 	96,077	  
	 Jazem IV Family Partners, LP

899 Northgate Drive, Suite 301, San
 Rafael, CA
94903
	  	 	 	 	  	 	 	 	  	 	48,237	  	  	 	 	 	  	 	48,237	  
	 The Fiddler and Alden Family Trust

899 Northgate Drive, Suite 301, San
 Rafael, CA
94903
	  	 	 	 	  	 	 	 	  	 	204,463	  	  	 	 	 	  	 	204,463	  
	 The Roda Group Investment Fund

XV, LLC
 The Roda Group

918 Parker Street
 Berkeley, CA
94710
	  	 	 	 	  	 	 	 	  	 	99,254	  	  	 	 	 	  	 	99,254	  
	 The Roda Group Investment Fund

XIX, LLC
 The Roda Group

918 Parker Street
 Berkeley, CA
94710
	  	 	 	 	  	 	 	 	  	 	1,163,702	  	  	 	 	 	  	 	1,163,702	  
	The Klitzner Family Trust 06/22/93	  	 	 	 	  	 	 	 	  	 	112,580	  	  	 	 	 	  	 	112,580	  
	 Ehrlich Family Trust

990 Highland Drive #303
 Solano Beach, CA
92075
	  	 	 	 	  	 	 	 	  	 	33,773	  	  	 	 	 	  	 	33,773	  
	Rick Lagatella	  	 	 	 	  	 	 	 	  	 	11,257	  	  	 	 	 	  	 	11,257	  
	 Dylan Simonds

29 Catalpa Avenue
 Mill Valley, CA
94941
	  	 	 	 	  	 	 	 	  	 	112,580	  	  	 	 	 	  	 	112,580	  
	Juliet Lea Hillman Simonds	  	 	 	 	  	 	 	 	  	 	225,161	  	  	 	 	 	  	 	225,161	  
	 Tyler Painter

225 Gateway Boulevard
 S. San Francisco, CA
94080
	  	 	 	 	  	 	 	 	  	 	2,250	  	  	 	 	 	  	 	2,250	  

  
 A-4

																					
	Name and Address	  	Series A
Shares	 	  	Series B
Shares	 	  	Series C
Shares	 	  	Series D
Shares	 	  	Total
Shares	 
	 San-Ei Gen F.F.I., Inc.

1-1-11, Sanwa-cho, Toyonaka
 Osaka, 561-8588,
Japan
	  	 	 	 	  	 	 	 	  	 	992,540	  	  	 	564,639	  	  	 	1,557,179	  
	 CTTV Investments LLC

6121 Bollinger Canyon Rd.,
 Rm. 5208

San Ramon, CA 94583
	  	 	 	 	  	 	 	 	  	 	397,016	  	  	 	 	 	  	 	397,016	  
	 J. Sandler Venture I, LLC

c/o The Sandler Foundation
 Four Embarcadero
Center
 Suite 3150
 San Francisco, CA
94111
	  	 	 	 	  	 	 	 	  	 	258,060	  	  	 	33,878	  	  	 	291,938	  
	 Howard Lasky

122 Howard Drive
 Tiburon, CA
94920
	  	 	 	 	  	 	 	 	  	 	9,925	  	  	 	 	 	  	 	9,925	  
	 Frederick S. Fields

2502 Washington Street
 San Francisco, CA
94115
	  	 	 	 	  	 	 	 	  	 	5,955	  	  	 	 	 	  	 	5,955	  
	 Jeffrey Knowles

One Ferry Building
 Suite 200

San Francisco, CA 94111
	  	 	 	 	  	 	 	 	  	 	4,962	  	  	 	 	 	  	 	4,962	  
	 Coblentz 1990 Revocable Trust

William K. Coblentz, Trustee
 10 Fifth
Avenue
 San Francisco, CA 94118
	  	 	 	 	  	 	 	 	  	 	4,962	  	  	 	 	 	  	 	4,962	  
	 James Mitchell

380 Georgetown Ave
 San Mateo, CA
94402
	  	 	 	 	  	 	 	 	  	 	4,962	  	  	 	 	 	  	 	4,962	  
	 Jeffry & Diane Bernstein Family
Trust
 U/A/D June 25, 2004
 One
Ferry Building
 Suite 200
 San
Francisco, CA 94111
	  	 	 	 	  	 	 	 	  	 	4,962	  	  	 	 	 	  	 	4,962	  
	 VPVP CleanTech Holdings

2006, L.L.C. 1001 Bayhill Drive
 Suite
300
 San Bruno, CA 94066
	  	 	 	 	  	 	 	 	  	 	238,210	  	  	 	 	 	  	 	238,210	  
	 VantagePoint Clean Tech Partners

II, L.P.
 1001 Bayhill Drive

Suite 300
 San Bruno, CA 94066
	  	 	 	 	  	 	 	 	  	 	357,314	  	  	 	 	 	  	 	357,314	  
	 Troy Campione

33 Ayer Avenue
 San Jose, CA
95110
	  	 	 	 	  	 	 	 	  	 	2,250	  	  	 	 	 	  	 	2,250	  

  
 A-5

																					
	Name and Address	  	Series A
Shares	 	  	Series B
Shares	 	  	Series C
Shares	 	  	Series D
Shares	 	  	Total
Shares	 
	 Solazyme Investments, LLC

340 Madison Avenue,
18th Floor

New York, NY 10173
	  	 	 	 	  	 	 	 	  	 	 	 	  	 	2,540,879	  	  	 	2,540,879	  
	 The Roda Group Investment Fund

XX, LLC
 The Roda Group

918 Parker Street
 Berkeley, CA
94710
	  	 	 	 	  	 	 	 	  	 	 	 	  	 	304,905	  	  	 	304,905	  
	 Spring Ventures, LLC

912 Cole Street #385
 San Francisco, CA
94117
	  	 	 	 	  	 	 	 	  	 	 	 	  	 	56,463	  	  	 	56,463	  

  
 A-6

 EXHIBIT B 
 FORM OF 
 CONSENT OF SPOUSE 

I,
                            , am the Spouse (as defined in the Third Amended and Restated
Investors’ Rights Agreement, dated as of May 19, 2010 (the “Agreement”), of
                                 [print name of stockholder], and acknowledge that
I have read the Agreement to which this Consent is attached and that I know the contents of the Agreement. I am aware that the Agreement contains provisions regarding the voting and/or transfer of shares of capital stock of the Company which my
spouse may own or may have a right to acquire, including any interest I might have therein. 
 I hereby agree that my interest,
if any, in any shares of capital stock of the Company subject to the Agreement shall be bound by the Agreement and further understand and agree that any community property interest I may have in such shares of capital stock of the Company shall be
similarly bound by the Agreement to the extent that my spouse is bound by the Agreement. 
 I am aware that the legal, financial
and related matters contained in the Agreement are complex and that I am free to seek independent professional guidance or counsel with respect to this Consent. I have either sought such guidance or counsel or determined after reviewing the
Agreement carefully that I waive such right. 
  

							
	Dated:	 	  
	 		  	  

		 		 		  	Print name of Spouse:

  
 B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}]]